| 1 |
Xian S, Zhu J, Wang Y, Song H, Wang H. Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice. Drug Deliv 2023;30:2183821. [PMID: 36861451 DOI: 10.1080/10717544.2023.2183821] [Reference Citation Analysis]
|
| 2 |
Cheng W, Wang X, Wu Y, Li W, Fu C, Zou L, Zhang J. Huanglian-Houpo extract attenuates DSS-induced UC mice by protecting intestinal mucosal barrier and regulating macrophage polarization. J Ethnopharmacol 2023;307:116181. [PMID: 36738944 DOI: 10.1016/j.jep.2023.116181] [Reference Citation Analysis]
|
| 3 |
Ghorbaninejad M, Asadzadeh-Aghdaei H, Baharvand H, Meyfour A. Intestinal organoids: A versatile platform for modeling gastrointestinal diseases and monitoring epigenetic alterations. Life Sci 2023;319:121506. [PMID: 36858311 DOI: 10.1016/j.lfs.2023.121506] [Reference Citation Analysis]
|
| 4 |
Shi W, Peng K, Yu H, Wang Z, Xia S, Xiao S, Tian D, Vallance BA, Yu Q. Autotaxin (ATX) inhibits autophagy leading to exaggerated disruption of intestinal epithelial barrier in colitis. Biochim Biophys Acta Mol Basis Dis 2023;1869:166647. [PMID: 36746254 DOI: 10.1016/j.bbadis.2023.166647] [Reference Citation Analysis]
|
| 5 |
Singh S, Boland BS, Jess T, Moore AA. Management of inflammatory bowel diseases in older adults. Lancet Gastroenterol Hepatol 2023;8:368-82. [PMID: 36669515 DOI: 10.1016/S2468-1253(22)00358-2] [Reference Citation Analysis]
|
| 6 |
Rasulov AO, Kulikov AE, Madyarov JM, Rasulov ZR. Colorectal cancer in ulcerative colitis (review). Koloproktologiâ 2023;22:138-146. [DOI: 10.33878/2073-7556-2023-22-1-138-146] [Reference Citation Analysis]
|
| 7 |
Xu J, Tang C, Din AU, Lu Y, Ma X, Zhang T, Wu J, Zuoqin D, Luo P, Wu J. Oligosaccharides of Polygonatum Cyrtonema Hua ameliorates dextran sulfate sodium-induced colitis and regulates the gut microbiota. Biomed Pharmacother 2023;161:114562. [PMID: 36934554 DOI: 10.1016/j.biopha.2023.114562] [Reference Citation Analysis]
|
| 8 |
Cui C, Wang X, Li L, Wei H, Peng J. Multifaceted involvements of Paneth cells in various diseases within intestine and systemically. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1115552] [Reference Citation Analysis]
|
| 9 |
Burisch J, Zhao M, Odes S, De Cruz P, Vermeire S, Bernstein CN, Kaplan GG, Duricova D, Greenberg D, Melberg HO, Watanabe M, Ahn HS, Targownik L, Pittet VEH, Annese V, Park KT, Katsanos KH, Høivik ML, Krznaric Z, Chaparro M, Loftus EV Jr, Lakatos PL, Gisbert JP, Bemelman W, Moum B, Gearry RB, Kappelman MD, Hart A, Pierik MJ, Andrews JM, Ng SC, D'Inca R, Munkholm P. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol 2023:S2468-1253(23)00003-1. [PMID: 36871566 DOI: 10.1016/S2468-1253(23)00003-1] [Reference Citation Analysis]
|
| 10 |
Vernon-Roberts A, Aluzaite K, Khalilipour B, Day AS. Systematic Review of Diagnostic Delay for Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2023;76:304-12. [PMID: 36730088 DOI: 10.1097/MPG.0000000000003670] [Reference Citation Analysis]
|
| 11 |
Shon WJ, Jung MH, Kim Y, Kang GH, Choi EY, Shin DM. Sugar-sweetened beverages exacerbate high-fat diet-induced inflammatory bowel disease by altering the gut microbiome. J Nutr Biochem 2023;113:109254. [PMID: 36572070 DOI: 10.1016/j.jnutbio.2022.109254] [Reference Citation Analysis]
|
| 12 |
Sáiz-chumillas RM, Barrio J, Fernández-salazar L, Arias L, Ausín MS, Piñero C, Fuentes Coronel A, Mata L, Vásquez M, Carbajo A, Alcaide N, Cano N, Nuñez A, Fradejas P, Ibáñez M, Hernández L, Sicilia B. Incidence and natural history of inflammatory bowel disease in Castile and León: A prospective, multicentre study. Gastroenterología y Hepatología (English Edition) 2023. [DOI: 10.1016/j.gastre.2022.04.009] [Reference Citation Analysis]
|
| 13 |
Yin M, Chen Y, Liu X, Tian S, Zhao L, Bai Y, Wang H, Lin J, Jiang D, Lei Z, Meng F, Tian D, Luo L. Targeted Computed Tomography Visualization and Healing of Inflammatory Bowel Disease by Orally Delivered Bacterial-Flagella-Inspired Polydiiododiacetylene Nanofibers. ACS Nano 2023;17:3873-88. [PMID: 36791326 DOI: 10.1021/acsnano.2c12154] [Reference Citation Analysis]
|
| 14 |
Saadh MJ, Pal RS, Arias-Gonzáles JL, Orosco Gavilán JC, Jc D, Mohany M, Al-Rejaie SS, Bahrami A, Kadham MJ, Amin AH, Georgia H. A Mendelian Randomization Analysis Investigates Causal Associations between Inflammatory Bowel Diseases and Variable Risk Factors. Nutrients 2023;15. [PMID: 36904201 DOI: 10.3390/nu15051202] [Reference Citation Analysis]
|
| 15 |
Li D, Gu W, Xu H, Zhang Z, Zhao C, He C, Zhu X, Li Y. Inflammation in the peripheral blood system of Crohn's Disease. Clin Exp Med 2023. [PMID: 36842094 DOI: 10.1007/s10238-023-01030-3] [Reference Citation Analysis]
|
| 16 |
Wang Y, Zhang Y, Lu B, Xi J, Ocansey DKW, Mao F, Hao D, Yan Y. hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts. Stem Cells Int 2023;2023:2828981. [PMID: 36845967 DOI: 10.1155/2023/2828981] [Reference Citation Analysis]
|
| 17 |
Yang R, Shan S, Shi J, Li H, An N, Li S, Cui K, Guo H, Li Z. Coprococcus eutactus, a Potent Probiotic, Alleviates Colitis via Acetate-Mediated IgA Response and Microbiota Restoration. J Agric Food Chem 2023. [PMID: 36786768 DOI: 10.1021/acs.jafc.2c06697] [Reference Citation Analysis]
|
| 18 |
Ghorbaninejad M, Abdollahpour-Alitappeh M, Shahrokh S, Fayazzadeh S, Asadzadeh-Aghdaei H, Meyfour A. TGF-β receptor I inhibitor may restrict the induction of EMT in inflamed intestinal epithelial cells. Exp Biol Med (Maywood) 2023;:15353702231151959. [PMID: 36775873 DOI: 10.1177/15353702231151959] [Reference Citation Analysis]
|
| 19 |
Alimam W, Nikkilä A, Raitanen J, Kolho KL, Auvinen A. Residential mobility and childhood inflammatory bowel disease: a nationwide case-control study. Ann Epidemiol 2023;80:53-61. [PMID: 36764587 DOI: 10.1016/j.annepidem.2023.02.003] [Reference Citation Analysis]
|
| 20 |
He Z, Wang Z, Song Y, Liu Y, Kang L, Fang X, Wang T, Fan X, Li Z, Wang S, Bai Y. The Reliability and Quality of Short Videos as a Source of Dietary Guidance for Inflammatory Bowel Disease: Cross-sectional Study. J Med Internet Res 2023;25:e41518. [PMID: 36757757 DOI: 10.2196/41518] [Reference Citation Analysis]
|
| 21 |
xie H, Zhang J, Liu C, Yang B, Dong W. Inflammatory bowel disease perception among Chinese patients: Development and Validation of a knowledge questionnaire.. [DOI: 10.21203/rs.3.rs-2534933/v1] [Reference Citation Analysis]
|
| 22 |
Tan X, Wen Y, Han Z, Su X, Peng J, Chen F, Wang Y, Wang T, Wang C, Ma K. Cinnamaldehyde Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating TLR4/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. Chem Biodivers 2023;20:e202200089. [PMID: 36653304 DOI: 10.1002/cbdv.202200089] [Reference Citation Analysis]
|
| 23 |
Liu JJ, Abraham BP, Adamson P, Barnes EL, Brister KA, Damas OM, Glover SC, Hooks K, Ingram A, Kaplan GG, Loftus EV, McGovern DPB, Narain-Blackwell M, Odufalu FD, Quezada S, Reeves V, Shen B, Stappenbeck TS, Ward L. The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients. Inflamm Bowel Dis 2023;29:297-307. [PMID: 35816130 DOI: 10.1093/ibd/izac124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Lin C, Zheng Y, Lu J, Zhang H, Wang G, Chen W. Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis. Life Sci 2023;314:121309. [PMID: 36563843 DOI: 10.1016/j.lfs.2022.121309] [Reference Citation Analysis]
|
| 25 |
de Oliveira ECS, Dalmau LM, de Almeida Costa CAR, de Almeida Junior LD, Ballard CR, Maróstica Junior MR, Stahl MA, Grimaldi R, Witaicenis A, Di Stasi LC. Dietary intervention with avocado (Persea americana Mill.) ameliorates intestinal inflammation induced by TNBS in rats. Inflammopharmacology 2023;31:485-98. [PMID: 36586042 DOI: 10.1007/s10787-022-01128-2] [Reference Citation Analysis]
|
| 26 |
Im H, Wang W, Qi Q, Li Q, Wu M, Wu H, Liu Y, Huang Y, Zhu Y, Zheng H, Wu L. Clinical efficacy of moxibustion for ulcerative colitis and its influence on vitamin D receptor. J Acupunct Tuina Sci 2023;21:40-50. [DOI: 10.1007/s11726-023-1357-5] [Reference Citation Analysis]
|
| 27 |
Gantzel RH, Vesterdal JD, Haase AM, Petersen AJ, Grønbæk H, Pedersen ML. The Prevalence of Inflammatory Bowel Disease in Greenland. Inflamm Bowel Dis 2023:izad002. [PMID: 36702537 DOI: 10.1093/ibd/izad002] [Reference Citation Analysis]
|
| 28 |
Xu W, Yang Y, Hua Z, Wang Y, Ding W, Lian L, Cui L, Wu X, Ding Z, Du P, Ye H. Intraoperative crystalloid-colloid infusion ratio associated with the development of early surgical complications after ileal pouch-anal anastomosis in ulcerative colitis: a multicenter long-term follow-up study. Int J Colorectal Dis 2023;38:15. [PMID: 36648457 DOI: 10.1007/s00384-023-04309-9] [Reference Citation Analysis]
|
| 29 |
Panés J, Loftus EV, Higgins PDR, Lindsay JO, Zhou W, Yao X, Ilo D, Phillips C, Tran J, Sanchez Gonzalez Y, Vermeire S. Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results. Inflamm Bowel Dis 2023:izac260. [PMID: 36645051 DOI: 10.1093/ibd/izac260] [Reference Citation Analysis]
|
| 30 |
Dou Y, Liu P, Ding Z, Zhou Y, Jing H, Ren Y, Heger Z, Adam V, Li N. Orally Administrable H(2) S-Scavenging Metal-Organic Framework Prepared by Co-Flow Microfluidics for Comprehensive Restoration of Intestinal Milieu. Adv Mater 2023;:e2210047. [PMID: 36637449 DOI: 10.1002/adma.202210047] [Reference Citation Analysis]
|
| 31 |
Shen JC, Qi Q, Han D, Lu Y, Huang R, Zhu Y, Zhang LS, Qin XD, Zhang F, Wu HG, Liu HR. Moxibustion improves experimental colitis in rats with Crohn's disease by regulating bile acid enterohepatic circulation and intestinal farnesoid X receptor. J Integr Med 2023:S2095-4964(23)00001-8. [PMID: 36740466 DOI: 10.1016/j.joim.2023.01.001] [Reference Citation Analysis]
|
| 32 |
Holmer AK, Luo J, Russ KB, Park S, Yang JY, Ertem F, Dueker J, Nguyen V, Hong S, Zenger C, Axelrad JE, Sofia A, Petrov JC, Al-Bawardy B, Fudman DI, Llano E, Dailey J, Jangi S, Khakoo N, Damas OM, Barnes EL, Scott FI, Ungaro RC, Singh S; Rising Educators Academics and Clinicians Helping-IBD (REACH-IBD). Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study. Clin Gastroenterol Hepatol 2023:S1542-3565(23)00029-0. [PMID: 36642291 DOI: 10.1016/j.cgh.2023.01.002] [Reference Citation Analysis]
|
| 33 |
Lin W, Liu S, Huang Z, Li H, Lu T, Luo Y, Zhong J, Xu Z, Liu Y, Li Y, Li P, Xu Q, Cai J, Li H, Chen XL. Mass cytometry and single-cell RNA sequencing reveal immune cell characteristics of active and inactive phases of Crohn's disease. Front Med (Lausanne) 2022;9:1064106. [PMID: 36714133 DOI: 10.3389/fmed.2022.1064106] [Reference Citation Analysis]
|
| 34 |
Seishima R, Okabayashi K, Ikeuchi H, Uchino M, Futami K, Noguchi T, Ohge H, Iseki Y, Watanabe K, Itabashi M, Okamoto K, Toiyama Y, Ogino T, Nakamura M, Yamada K, Wakai T, Sato Y, Kimura H, Takahashi K, Hida K, Kinugasa Y, Ishida F, Okuda J, Daito K, Koyama F, Ueno H, Yamamoto T, Yamamoto S, Hanai T, Maemoto A, Arakaki J, Komori K, Akagi Y, Shida D, Yamaguchi S, Matsuda K, Maeda K, Noake T, Nezu R, Sasaki S, Hasegawa J, Sunami E, Kanemitsu Y, Katsumata K, Uehara K, Kiyomatsu T, Suto T, Kazama S, Yamada T, Goi T, Ishihara S, Ajioka Y, Sugihara K. Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study. Am J Gastroenterol 2023. [PMID: 36622356 DOI: 10.14309/ajg.0000000000002149] [Reference Citation Analysis]
|
| 35 |
Baer HM, Sandilya S, Steiner TS. Evading the Toll booth: How "silent" flagellins may bind yet fail to activate TLR5. Sci Immunol 2023;8:eadf0244. [PMID: 36608148 DOI: 10.1126/sciimmunol.adf0244] [Reference Citation Analysis]
|
| 36 |
Guo J, Wang F, Hu Y, Luo Y, Wei Y, Xu K, Zhang H, Liu H, Bo L, Lv S, Sheng S, Zhuang X, Zhang T, Xu C, Chen X, Su J. Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases. Cell Rep Med 2023;4:100881. [PMID: 36603578 DOI: 10.1016/j.xcrm.2022.100881] [Reference Citation Analysis]
|
| 37 |
Alzahrani A, Alzahrani AJ, Shori AB. Inflammatory Bowel Disease: A focus on the Role of Probiotics in Ulcerative Colitis. Open Access Maced J Med Sci 2023;11:44-52. [DOI: 10.3889/oamjms.2023.11020] [Reference Citation Analysis]
|
| 38 |
Heo G, Kim Y, Kim EL, Park S, Rhee SH, Jung JH, Im E. Atractylodin Ameliorates Colitis via PPARα Agonism. Int J Mol Sci 2023;24. [PMID: 36614242 DOI: 10.3390/ijms24010802] [Reference Citation Analysis]
|
| 39 |
Xu J, Xu J, Shi T, Zhang Y, Chen F, Yang C, Guo X, Liu G, Shao D, Leong KW, Nie G. Probiotic-Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiome. Adv Mater 2023;35:e2207890. [PMID: 36341495 DOI: 10.1002/adma.202207890] [Reference Citation Analysis]
|
| 40 |
Cecerska-Heryć E, Ronkowski B, Heryć R, Serwin N, Grygorcewicz B, Roszak M, Galant K, Dołęgowska B. Proteomic and lipidomic biomarkers in the diagnosis and progression of inflammatory bowel disease - a review. Proteomics Clin Appl 2023;17:e2200003. [PMID: 36043901 DOI: 10.1002/prca.202200003] [Reference Citation Analysis]
|
| 41 |
Truta B, Begum F, Datta LW, Brant SR; NIDDK IBD Genetics Consortium. Inflammatory Bowel Diseases Before and After 1990. Gastro Hep Adv 2023;2:22-32. [PMID: 36686985 DOI: 10.1016/j.gastha.2022.08.001] [Reference Citation Analysis]
|
| 42 |
Noguchi T, Ishihara S, Uchino M, Ikeuchi H, Okabayashi K, Futami K, Tanaka S, Ohge H, Nagahara H, Watanabe K, Itabashi M, Okamoto K, Okita Y, Mizushima T, Mizuuchi Y, Yamada K, Shimada Y, Sato Y, Kimura H, Takahashi K, Hida K, Kinugasa Y, Okuda J, Daito K, Koyama F, Ueno H, Yamamoto T, Hanai T, Maemoto A, Oba K, Ajioka Y, Sugihara K; Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by the Japanese Society for Cancer of the Colon, Rectum. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn's disease. J Gastroenterol 2023;58:14-24. [PMID: 36182971 DOI: 10.1007/s00535-022-01927-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 43 |
Nie Q, Li C, Wang Y, Hu Y, Pu W, Zhang Q, Cai J, Lin Y, Li G, Wang C, Li L, Dou Y, Zhang J. Pathologically triggered in situ aggregation of nanoparticles for inflammation-targeting amplification and therapeutic potentiation. Acta Pharm Sin B 2023;13:390-409. [PMID: 36815041 DOI: 10.1016/j.apsb.2022.07.013] [Reference Citation Analysis]
|
| 44 |
Koletzko S, Weise U. CED bei Kindern und Jugendlichen. Pflege bei chronisch-entzündlichen Darmerkrankungen 2023. [DOI: 10.1007/978-3-662-64938-1_25] [Reference Citation Analysis]
|
| 45 |
Aden K. Mechanismen der Krankheitsentstehung. Pflege bei chronisch-entzündlichen Darmerkrankungen 2023. [DOI: 10.1007/978-3-662-64938-1_2] [Reference Citation Analysis]
|
| 46 |
Jiang J, Chen L, Sun R, Yu T, Jiang S, Chen H. Characterization of serum polyunsaturated fatty acid profile in patients with inflammatory bowel disease. Therapeutic Advances in Chronic Disease 2023;14:204062232311568. [DOI: 10.1177/20406223231156826] [Reference Citation Analysis]
|
| 47 |
Zhao Y, Wang S, Hu Y, Wang Y. Investigating Key Targets of Dajianzhong Decoction for Treating Crohn’s Disease Using Weighted Gene Co-Expression Network. Processes 2022;11:112. [DOI: 10.3390/pr11010112] [Reference Citation Analysis]
|
| 48 |
Liu J, Liu S, Cao H, Shi B, Li Q, Shan J, Yuan J, Lin J. Pharmacology Mechanism of Polygonum Bistorta in Treating Ulcerative Colitis Based on Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-18. [DOI: 10.1155/2022/6461560] [Reference Citation Analysis]
|
| 49 |
Zhu Y, Wang Q, Chen Y, Xie Y, Han G, Liu S, Song Y, Lu W, Guo Y. Living Probiotics-Loaded Hydrogel Microspheres with Gastric Acid Resistance and ROS Triggered Release for Potential Therapy of Inflammatory Bowel Disease. ACS Appl Polym Mater 2022. [DOI: 10.1021/acsapm.2c01893] [Reference Citation Analysis]
|
| 50 |
Liu Y, Zeng S, Huang C, Wang C, Zhu J, Peng J, Ding F, Li J, Qin G, Chen J. Indoor Solid Fuel Use and Non-Neoplastic Digestive System Diseases: A Population-Based Cohort Study Among Chinese Middle-Aged and Older Population. Int J Public Health 2022;67:1605419. [PMID: 36618433 DOI: 10.3389/ijph.2022.1605419] [Reference Citation Analysis]
|
| 51 |
Wang S, Cui J, Jiang S, Zheng C, Zhao J, Zhang H, Zhai Q. Early life gut microbiota: Consequences for health and opportunities for prevention. Critical Reviews in Food Science and Nutrition 2022. [DOI: 10.1080/10408398.2022.2158451] [Reference Citation Analysis]
|
| 52 |
Zhang B, Zhao C, Zhang X, Li X, Zhang Y, Liu X, Yin J, Li X, Wang J, Wang S. An Elemental Diet Enriched in Amino Acids Alters the Gut Microbial Community and Prevents Colonic Mucus Degradation in Mice with Colitis. mSystems 2022;7:e0088322. [PMID: 36468853 DOI: 10.1128/msystems.00883-22] [Reference Citation Analysis]
|
| 53 |
Qu J, Shao C, Ying Y, Wu Y, Liu W, Tian Y, Yin Z, Li X, Yu Z, Shuai J. The spring-like effect of microRNA-31 in balancing inflammatory and regenerative responses in colitis. Front Microbiol 2022;13:1089729. [PMID: 36590397 DOI: 10.3389/fmicb.2022.1089729] [Reference Citation Analysis]
|
| 54 |
Oliveira ALS, Carvalho MJ, Oliveira DL, Costa E, Pintado M, Madureira AR. Sugarcane Straw Polyphenols as Potential Food and Nutraceutical Ingredient. Foods 2022;11. [PMID: 36553767 DOI: 10.3390/foods11244025] [Reference Citation Analysis]
|
| 55 |
Mann E, Shekarriz S, Surette MG. Human Gut Metagenomes Encode Diverse GH156 Sialidases. Appl Environ Microbiol 2022;88:e0175522. [PMID: 36394327 DOI: 10.1128/aem.01755-22] [Reference Citation Analysis]
|
| 56 |
Zhang Y, Wang C, lexi W, Bai C, Huang K, Yao L, Zhang Z, Ye L, Liu R, Ge X, Xu M, Xiao P, Zhao Y, Cao Q. Epithelial CRL4 DCAF2 is critical for maintaining intestinal homeostasis by regulating the proliferation and repair of intestinal epithelial cells.. [DOI: 10.21203/rs.3.rs-2291247/v1] [Reference Citation Analysis]
|
| 57 |
Setshedi M, Watermeyer G. The impact of Helicobacter pylori and intestinal helminth infections on gastric adenocarcinoma and inflammatory bowel disease in Sub-Saharan Africa. Front Med (Lausanne) 2022;9:1013779. [PMID: 36569142 DOI: 10.3389/fmed.2022.1013779] [Reference Citation Analysis]
|
| 58 |
Yokoyama Y, Ohta Y, Ogasawara S, Kato J, Arai R, Koseki H, Saito M, Kaneko T, Tokunaga M, Oura H, Oike T, Imai Y, Kanayama K, Akizue N, Kumagai J, Taida T, Okimoto K, Saito K, Ooka Y, Matsumura T, Nakagawa T, Arai M, Katsuno T, Fukuda Y, Kitsukawa Y, Kato N. The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort. Sci Rep 2022;12:21060. [PMID: 36473879 DOI: 10.1038/s41598-022-25218-x] [Reference Citation Analysis]
|
| 59 |
Hörning A, Schmidt-choudhury A. Enterale Ernährungstherapien beim pädiatrischen M. Crohn. Kinder- und Jugendmedizin 2022;22:439-449. [DOI: 10.1055/a-1954-7864] [Reference Citation Analysis]
|
| 60 |
D'Aloisio LD, Shetty V, Ballal M, Gibson DL. Following the Indian Immigrant: adoption of westernization results in a western gut microbiome and an increased risk of inflammatory bowel diseases. FEMS Microbiol Ecol 2022;98:fiac133. [PMID: 36370451 DOI: 10.1093/femsec/fiac133] [Reference Citation Analysis]
|
| 61 |
Kim JS, Kim HK, Kim M, Jang S, Cho E, Mun SJ, Lee J, Hong D, Yoon S, Yang CS. Colon-Targeted eNAMPT-Specific Peptide Systems for Treatment of DSS-Induced Acute and Chronic Colitis in Mouse. Antioxidants (Basel) 2022;11. [PMID: 36552583 DOI: 10.3390/antiox11122376] [Reference Citation Analysis]
|
| 62 |
Windfelder AG, Müller FHH, Mc Larney B, Hentschel M, Böhringer AC, von Bredow CR, Leinberger FH, Kampschulte M, Maier L, von Bredow YM, Flocke V, Merzendorfer H, Krombach GA, Vilcinskas A, Grimm J, Trenczek TE, Flögel U. High-throughput screening of caterpillars as a platform to study host-microbe interactions and enteric immunity. Nat Commun 2022;13:7216. [PMID: 36433960 DOI: 10.1038/s41467-022-34865-7] [Reference Citation Analysis]
|
| 63 |
Kontola K, Oksanen P, Huhtala H, Jussila A. Increasing incidence of inflammatory bowel disease with greatest change among the elderly: a nationwide study in Finland, 2000-2020. J Crohns Colitis 2022:jjac177. [PMID: 36420953 DOI: 10.1093/ecco-jcc/jjac177] [Reference Citation Analysis]
|
| 64 |
Krarup AL, Larsen L, Nayeb AB, Grøntved S, Paaske Johnsen S, Esbjørn M, Fallingborg J, Nielsen GL, Allin K, Jess T, Olesen AE. Less prevalent use of biologics for inflammatory bowel disease in patients from Non-Academic hospitals - a Danish register-based study of a region with 580,000 citizens. Scand J Gastroenterol 2022;:1-6. [PMID: 36356318 DOI: 10.1080/00365521.2022.2143726] [Reference Citation Analysis]
|
| 65 |
Vissers E, Wellens J, Sabino J. Ultra-processed foods as a possible culprit for the rising prevalence of inflammatory bowel diseases. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1058373] [Reference Citation Analysis]
|
| 66 |
Rosso AD, Aguilera P, Quesada S, Mascardi F, Mascuka SN, Cimolai MC, Cerezo J, Spiazzi R, Conlon C, Milano C, Iraola GM, Penas-steinhardt A, Belforte FS. Comprehensive Phenotyping in Inflammatory Bowel Disease: Search for Biomarker Algorithms in the Transkingdom Interactions Context. Microorganisms 2022;10:2190. [DOI: 10.3390/microorganisms10112190] [Reference Citation Analysis]
|
| 67 |
Limketkai BN, Hamideh M, Shah R, Sauk JS, Jaffe N. Dietary Patterns and Their Association With Symptoms Activity in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2022;28:1627-36. [PMID: 35092268 DOI: 10.1093/ibd/izab335] [Reference Citation Analysis]
|
| 68 |
Yang W, Tao K, Wang Y, Huang Y, Duan C, Wang T, Li C, Zhang P, Yin Y, Gao J, Li R. Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115338] [Reference Citation Analysis]
|
| 69 |
Magrì S, Demurtas M, Onidi MF, Picchio M, Elisei W, Marzo M, Miculan F, Manca R, Dore MP, Quarta Colosso BM, Cicu A, Cugia L, Carta M, Binaghi L, Usai P, Lai M, Chicco F, Fantini MC, Armuzzi A, Mocci G. Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicenter study. World J Clin Cases 2022; 10(30): 10921-10930 [DOI: 10.12998/wjcc.v10.i30.10921] [Reference Citation Analysis]
|
| 70 |
Shao B, Yang W, Cao Q. Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030. Front Public Health 2022;10:1032679. [PMID: 36388296 DOI: 10.3389/fpubh.2022.1032679] [Reference Citation Analysis]
|
| 71 |
Meyer A, Dong C, Casagrande C, Chan SSM, Huybrechts I, Nicolas G, Rauber F, Levy RB, Millett C, Oldenburg B, Weiderpass E, Heath AK, Tong TYN, Tjønneland A, Kyrø C, Kaaks R, Katzke VA, Bergman MM, Palli D, Masala G, Tumino R, Sacerdote C, Colorado-Yohar SM, Sánchez MJ, Grip O, Lindgren S, Luben R, Gunter MJ, Mahamat-Saleh Y, Boutron-Ruault MC, Carbonnel F. Food Processing and Risk of Crohn's Disease and Ulcerative Colitis: A European Prospective Cohort Study. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00929-6. [PMID: 36243353 DOI: 10.1016/j.cgh.2022.09.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Yu XT, Chen M, Guo J, Zhang J, Zeng T. Noninvasive detection and interpretation of gastrointestinal diseases by collaborative serum metabolite and magnetically controlled capsule endoscopy. Comput Struct Biotechnol J 2022;20:5524-34. [PMID: 36249561 DOI: 10.1016/j.csbj.2022.10.001] [Reference Citation Analysis]
|
| 73 |
Zhu F, Qin Y, Wang Y, Zhang F, Xu Z, Dai F, Chu W, Wang Y, Zhou G. Critical roles of RGS16 in the mucosal inflammation of ulcerative colitis. Eur J Gastroenterol Hepatol 2022;34:993-9. [PMID: 35830366 DOI: 10.1097/MEG.0000000000002407] [Reference Citation Analysis]
|
| 74 |
Yin J, Li Y, Chen Y, Wang C, Song X. Adalimumab for induction of remission in patients with Crohn's disease: a systematic review and meta-analysis. Eur J Med Res 2022;27:190. [PMID: 36175983 DOI: 10.1186/s40001-022-00817-6] [Reference Citation Analysis]
|
| 75 |
Liu Y, Yan H, Yu B, He J, Mao X, Yu J, Zheng P, Huang Z, Luo Y, Luo J, Wu A, Chen D. Protective Effects of Natural Antioxidants on Inflammatory Bowel Disease: Thymol and Its Pharmacological Properties. Antioxidants 2022;11:1947. [DOI: 10.3390/antiox11101947] [Reference Citation Analysis]
|
| 76 |
Heetmeyer J, Schwerd T. Chronisch-entzündliche Darmerkrankungen. Monatsschr Kinderheilkd 2022. [DOI: 10.1007/s00112-022-01604-7] [Reference Citation Analysis]
|
| 77 |
Wang J, Li Z, Xiao J, Wu L, Chen K, Zhu T, Feng C, Zhuansun D, Meng X, Feng J. Identification and validation of the common pathogenesis and hub biomarkers in Hirschsprung disease complicated with Crohn’s disease. Front Immunol 2022;13:961217. [DOI: 10.3389/fimmu.2022.961217] [Reference Citation Analysis]
|
| 78 |
Dawoodi S, Dawoodi I, Dixit P. Gastrointestinal problem among Indian adults: Evidence from longitudinal aging study in India 2017-18. Front Public Health 2022;10:911354. [PMID: 36225774 DOI: 10.3389/fpubh.2022.911354] [Reference Citation Analysis]
|
| 79 |
Afzaal M, Saeed F, Shah YA, Hussain M, Rabail R, Socol CT, Hassoun A, Pateiro M, Lorenzo JM, Rusu AV, Aadil RM. Human gut microbiota in health and disease: Unveiling the relationship. Front Microbiol 2022;13:999001. [DOI: 10.3389/fmicb.2022.999001] [Reference Citation Analysis]
|
| 80 |
Chiba M, Komatsu M, Hosoba M, Hatano K, Takeda M. Onset of Ulcerative Colitis in a Patient with Type 2 Diabetes: Efficacy of a Plant-Based Diet for Both Diseases. Gastrointestinal Disorders 2022;4:223-229. [DOI: 10.3390/gidisord4040021] [Reference Citation Analysis]
|
| 81 |
Liu C, Yu R, Zhang J, Wei S, Xue F, Guo Y, He P, Shang L, Dong W. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021. Front Immunol 2022;13:972079. [DOI: 10.3389/fimmu.2022.972079] [Reference Citation Analysis]
|
| 82 |
Shang J, Yang S, Tang Z, Chen Y, Duan B, Meng X. Bifidobacterium bifidum H3-R2 and Its Molecular Communication within the Context of Ulcerative Colitis. J Agric Food Chem 2022. [PMID: 36095239 DOI: 10.1021/acs.jafc.2c02909] [Reference Citation Analysis]
|
| 83 |
Wu L, Lv Z, Lai L, Zhou P. Assessment of influencing factors of hospitalization expenses for Crohn's disease patients: Based on LASSO and linear mixed model. Front Public Health 2022;10:925616. [PMID: 36159299 DOI: 10.3389/fpubh.2022.925616] [Reference Citation Analysis]
|
| 84 |
Liu D, Chen Y, Li Q, Xu M, Liao J, Wang B. Integrative bioinformatics analysis to identify the effects of circadian rhythm on Crohn’s disease. Front Mol Biosci 2022;9:961481. [DOI: 10.3389/fmolb.2022.961481] [Reference Citation Analysis]
|
| 85 |
Trakman GL, Lin WYY, Hamilton AL, Wilson-O'Brien AL, Stanley A, Ching JY, Yu J, Mak JWY, Sun Y, Niu J, Miao Y, Lin X, Feng R, Chen M, Shivappa N, Hebert JR, Morrison M, Ng SC, Kamm MA. Processed Food as a Risk Factor for the Development and Perpetuation of Crohn's Disease-The ENIGMA Study. Nutrients 2022;14:3627. [PMID: 36079885 DOI: 10.3390/nu14173627] [Reference Citation Analysis]
|
| 86 |
Oli AK, Maidur RN, Hurkadli PS, Javalgi AP, Javaregowda PK, Goni M. INCIDENCE OF INFLAMMATORY BOWEL DISEASE: A SINGLE CENTRE RETROSPECTIVE STUDY. Arq Gastroenterol 2022;59:345-351. [DOI: 10.1590/s0004-2803.202203000-63] [Reference Citation Analysis]
|
| 87 |
Renuzza SSS, Vieira ER, Cornel CA, Lima MN, Ramos Junior O. INCIDENCE, PREVALENCE, AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASES IN THE STATE OF PARANÁ IN SOUTHERN BRAZIL. Arq Gastroenterol 2022;59:327-333. [DOI: 10.1590/s0004-2803.202203000-60] [Reference Citation Analysis]
|
| 88 |
Preda C, Istrătescu D. Etiology of Ulcerative Colitis. Ulcerative Colitis [Working Title] 2022. [DOI: 10.5772/intechopen.106842] [Reference Citation Analysis]
|
| 89 |
Tracy M, Khalili H. You Are What You Eat? Growing Evidence That Diet Influences the Risk of Inflammatory Bowel Disease. J Crohns Colitis 2022;16:1185-6. [PMID: 35194635 DOI: 10.1093/ecco-jcc/jjac025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 90 |
Loktionov A. Colon mucus in colorectal neoplasia and beyond. World J Gastroenterol 2022; 28(32): 4475-4492 [DOI: 10.3748/wjg.v28.i32.4475] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 91 |
Cota D, Patil D. Antibacterial potential of ellagic acid and gallic acid against IBD bacterial isolates and cytotoxicity against colorectal cancer. Nat Prod Res 2022;:1-5. [PMID: 35968644 DOI: 10.1080/14786419.2022.2111560] [Reference Citation Analysis]
|
| 92 |
Guo H, Guo H, Xie Y, Chen Y, Lu C, Yang Z, Zhu Y, Ouyang Y, Zhang Y, Wang X. Mo3Se4 nanoparticle with ROS scavenging and multi-enzyme activity for the treatment of DSS-induced colitis in mice. Redox Biol 2022;56:102441. [PMID: 35985164 DOI: 10.1016/j.redox.2022.102441] [Reference Citation Analysis]
|
| 93 |
Cassol OS, Zabot GP, Saad-Hossne R, Padoin A. Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil. World J Gastroenterol 2022; 28(30): 4174-4181 [DOI: 10.3748/wjg.v28.i30.4174] [Reference Citation Analysis]
|
| 94 |
Bao J, Ye B, Ren Y, Yang J. ABIN1 Inhibits Inflammation through Necroptosis-Dependent Pathway in Ulcerative Colitis. Genetics Research 2022;2022:1-8. [DOI: 10.1155/2022/9313559] [Reference Citation Analysis]
|
| 95 |
Hu Y, Jin X, Gao F, Lin T, Zhu H, Hou X, Yin Y, Kan S, Chen D. Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front Microbiol 2022;13:955112. [DOI: 10.3389/fmicb.2022.955112] [Reference Citation Analysis]
|
| 96 |
Soleto I, Fernández-tomé S, Mora-gutiérrez I, Baldan-martin M, Ramírez C, Santander C, Moreno-monteagudo JA, Casanova MJ, Casals F, Casabona S, Becerro I, Chaparro M, Bernardo D, Gisbert JP. Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease. Biomedicines 2022;10:1885. [DOI: 10.3390/biomedicines10081885] [Reference Citation Analysis]
|
| 97 |
Sato M, Fujii K, Takagi H, Shibuya I, Oka D, Yamaya N, Hagita H, Matsumoto M, Inagaki K. Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease. Dig Dis Sci 2022;67:3993-4007. [DOI: 10.1007/s10620-021-07237-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 98 |
Fukuda S, Akiyama S, Tarakji A, Hamdeh S, Suzuki H, Tsuchiya K. Prevalence and clinical features of patients with autoimmune pancreatitis and inflammatory bowel disease: A systematic review and meta-analysis. J Gastroenterol Hepatol 2022;37:1474-84. [PMID: 35596263 DOI: 10.1111/jgh.15894] [Reference Citation Analysis]
|
| 99 |
Kokulnathan T, Wang T, Ahmed F, Alshahrani T. Hydrothermal Synthesis of ZnCr-LDH/Tungsten Carbide Composite: A Disposable Electrochemical Strip for Mesalazine Analysis. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.138884] [Reference Citation Analysis]
|
| 100 |
Hasan B, Ur Rahman A. Ulcerative Colitis and Diverticulitis Are Possibly Connected to the Same Hub. Inflamm Bowel Dis 2022;28:e125. [PMID: 35460402 DOI: 10.1093/ibd/izac057] [Reference Citation Analysis]
|
| 101 |
Yu S, Sun Y, Shao X, Zhou Y, Yu Y, Kuai X, Zhou C. Leaky Gut in IBD: Intestinal Barrier-Gut Microbiota Interaction. J Microbiol Biotechnol 2022;32:825-34. [PMID: 35791076 DOI: 10.4014/jmb.2203.03022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 102 |
Roukas C, Syred J, Gordeev VS, Norton C, Hart A, Mihaylova B. Development and test-retest reliability of a new, self-report questionnaire assessing healthcare use and personal costs in people with inflammatory bowel disease: the Inflammatory Bowel Disease Resource Use Questionnaire (IBD-RUQ). Frontline Gastroenterol 2023;14:59-67. [PMID: 36561790 DOI: 10.1136/flgastro-2022-102182] [Reference Citation Analysis]
|
| 103 |
Peng C, Li J, Miao Z, Wang Y, Wu S, Wang Y, Wang S, Cheng R, He F, Shen X. Early life administration of Bifidobacterium bifidum BD-1 alleviates long-term colitis by remodeling the gut microbiota and promoting intestinal barrier development. Front Microbiol 2022;13:916824. [DOI: 10.3389/fmicb.2022.916824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 104 |
Buie MJ, Quan J, Windsor JW, Coward S, Hansen TM, King JA, Kotze PG, Gearry RB, Ng SC, Mak JWY, Abreu MT, Rubin DT, Bernstein CN, Banerjee R, Yamamoto-Furusho JK, Panaccione R, Seow CH, Ma C, Underwood FE, Ahuja V, Panaccione N, Shaheen AA, Holroyd-Leduc J, Kaplan GG, Balderramo D, Chong VH, Juliao-Baños F, Dutta U, Simadibrata M, Kaibullayeva J, Sun Y, Hilmi I, Raja Ali RA, Paudel MS, Altuwaijri M, Hartono JL, Wei SC, Limsrivilai J, El Ouali S, Vergara BI, Dao VH, Kelly P, Hodges P, Miao Y, Li M; Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00670-X. [PMID: 35863682 DOI: 10.1016/j.cgh.2022.06.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 105 |
Liang H, Zhang F, Wang W, Zhao W, Zhou J, Feng Y, Wu J, Li M, Bai X, Zeng Z, Niu J, Miao Y. Heat Shock Transcription Factor 2 Promotes Mitophagy of Intestinal Epithelial Cells Through PARL/PINK1/Parkin Pathway in Ulcerative Colitis. Front Pharmacol 2022;13:893426. [DOI: 10.3389/fphar.2022.893426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 106 |
Konturek PC. Darmmikrobiom und chronisch- entzündliche Darmerkrankung. MMW - Fortschritte der Medizin 2022;164:12-15. [DOI: 10.1007/s15006-022-1230-3] [Reference Citation Analysis]
|
| 107 |
Juliao-baños F, Grillo-ardila C, Alfaro I, Andara-ramírez M, Avelar-escobar O, Barahona-garrido J, Bautista-martínez S, Bosques-padilla F, De Paula J, Ernest-suárez K, Galiano M, Iade-vergara B, Patricio-ibañez, Jara-alba M, Kotze P, Miranda-ojeda M, Ortuño-escalante R, Otoya-moreno G, Piñol-jiménez F, Ramos-polo I, Sambuelli A, Toro M, Torres E, Veitia-velásquez G, Yamamoto-furusho J, Zaltman C, Steinwurz F, Vallejo-ortega M, Torres-castillo J, Hamon-pinilla C, Calderón-franco C, Escobar-villegas A. Actualización de la guía de práctica clínica PANCCO para el tratamiento de la colitis ulcerativa en población adulta. Revista de Gastroenterología de México 2022;87:342-361. [DOI: 10.1016/j.rgmx.2022.04.007] [Reference Citation Analysis]
|
| 108 |
Juliao-baños F, Grillo-ardila C, Alfaro I, Andara-ramírez M, Avelar-escobar O, Barahona-garrido J, Bautista-martínez S, Bosques-padilla F, De Paula J, Ernest-suárez K, Galiano M, Iade-vergara B, Patricio-ibañez, Jara-alba M, Kotze P, Miranda-ojeda M, Ortuño-escalante R, Otoya- Moreno G, Piñol-jiménez F, Ramos-polo I, Sambuelli A, Toro M, Torres E, Veitia-velásquez G, Yamamoto-furusho J, Zaltman C, Steinwurz F, Vallejo-ortega M, Torres-castillo J, Hamon-pinilla C, Calderon-franco C, Escobar-villegas A. Update of the PANCCO clinical practice guidelines for the treatment of ulcerative colitis in the adult population. Revista de Gastroenterología de México (English Edition) 2022;87:342-361. [DOI: 10.1016/j.rgmxen.2022.04.006] [Reference Citation Analysis]
|
| 109 |
Mann E, Shekarriz S, Surette MG. Human gut metagenomes encode diverse GH156 sialidases.. [DOI: 10.1101/2022.06.28.497753] [Reference Citation Analysis]
|
| 110 |
Arjomand Fard N, Armstrong H, Perry T, Wine E. Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies? Inflamm Bowel Dis 2023;29:151-60. [PMID: 35749298 DOI: 10.1093/ibd/izac106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 111 |
Zhang R, Zhang Q, Chen Y, Zhao Q, Zhang B, Wang L, Zhou C, Zhang Q, Chen K, Zhang Y, Hou X, Chen H, Liu X, Ni M, Jiang B. Combined treatment with Rg1 and adipose-derived stem cells alleviates DSS-induced colitis in a mouse model. Stem Cell Res Ther 2022;13:272. [PMID: 35729638 DOI: 10.1186/s13287-022-02940-x] [Reference Citation Analysis]
|
| 112 |
Xu X, Ocansey DKW, Hang S, Wang B, Amoah S, Yi C, Zhang X, Liu L, Mao F. The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease. Gut Pathog 2022;14:26. [PMID: 35729658 DOI: 10.1186/s13099-022-00499-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 113 |
Baig MMA, Irfan SA, Sumbal A, Sumbal R, Kumar S, Ahmad J, Gandrakota N, Qadar LT, Chaudhry MS, Feroz A, Warraich MS. Prevalence of Gallstones in Ulcerative Colitis and Crohn’s Disease: A Systematic Review and Meta-Analysis. Cureus 2022. [DOI: 10.7759/cureus.26121] [Reference Citation Analysis]
|
| 114 |
Magro F, Portela F, Lago P, Chagas C, Moreira F, Pereira F, Rodrigues B, Pedrosa H, Correia L. Burden of Disease and Cost of Illness of Inflammatory Bowel Diseases in Portugal. GE Port J Gastroenterol 2022. [DOI: 10.1159/000525206] [Reference Citation Analysis]
|
| 115 |
Vila AV, Hu S, Andreu-sánchez S, Collij V, Jansen BH, Augustijn HE, Bolte L, Ruigrok RA, Abu-ali G, Giallourakis C, Schneider J, Parkinson J, Garawi AA, Zhernakova A, Gacesa R, Fu J, Weersma RK. The faecal metabolome and its determinants in inflammatory bowel disease.. [DOI: 10.1101/2022.06.15.495746] [Reference Citation Analysis]
|
| 116 |
Goh XT, Fong SK, Chai HC, Kee BP, Chua KH. The first association study of Protein Tyrosine Phosphatase, Non-Receptor Type 2 (PTPN2) gene polymorphisms in Malaysian patients with Crohn's disease. Gene 2022;836:146661. [PMID: 35680018 DOI: 10.1016/j.gene.2022.146661] [Reference Citation Analysis]
|
| 117 |
Clarkston K, Karns R, Jegga AG, Sharma M, Fox S, Ojo BA, Minar P, Walters TD, Griffiths AM, Mack DR, Boyle B, LeLeiko NS, Markowitz J, Rosh JR, Patel AS, Shah S, Baldassano RN, Pfefferkorn M, Sauer C, Kugathasan S, Haberman Y, Hyams JS, Denson LA, Rosen MJ. Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis. J Crohns Colitis 2022;16:1735-50. [PMID: 35665804 DOI: 10.1093/ecco-jcc/jjac075] [Reference Citation Analysis]
|
| 118 |
Zhang B, Zhao C, Zhang Y, Zhang X, Li X, Liu X, Yin J, Li X, Wang J, Wang S. Elemental diet enriched in amino acids alters gut microbial community and prevents colonic mucus degradation in mice with colitis.. [DOI: 10.1101/2022.06.01.494459] [Reference Citation Analysis]
|
| 119 |
Peng L, Hu S, Yu Q, Chen Y. Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease. Inflamm Bowel Dis 2022;28:S9-S15. [PMID: 34984463 DOI: 10.1093/ibd/izab344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 120 |
Lo TC, Chen YY, Chen HH. Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study. Eye (Lond) 2022;36:1288-93. [PMID: 34155367 DOI: 10.1038/s41433-021-01645-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 121 |
Aghamohammad S, Sepehr A, Miri ST, Najafi S, Pourshafie MR, Rohani M. Anti‐inflammatory and immunomodulatory effects of Lactobacillus spp. as a preservative and therapeutic agent for IBD control. Immunity Inflam & Disease 2022;10. [DOI: 10.1002/iid3.635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 122 |
Huang C, Xu J, Li J, He S, Xu H, Ren X, Singh V, Wu L, Zhang J. Hydrogen peroxide responsive covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease. Carbohydrate Polymers 2022;285:119252. [DOI: 10.1016/j.carbpol.2022.119252] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 123 |
Loubet Filho PS, Dias TO, Reis VHDOT, Moya AMTM, Santos EFD, Cazarin CBB. Feed your gut: Functional food to improve the pathophysiology of inflammatory bowel disease. Journal of Functional Foods 2022;93:105073. [DOI: 10.1016/j.jff.2022.105073] [Reference Citation Analysis]
|
| 124 |
Watermeyer G, Katsidzira L, Setshedi M, Devani S, Mudombi W, Kassianides C. Inflammatory bowel disease in sub-Saharan Africa: epidemiology, risk factors, and challenges in diagnosis. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(22)00047-4] [Reference Citation Analysis]
|
| 125 |
Li M, Zhang R, Li J, Li J. The Role of C-Type Lectin Receptor Signaling in the Intestinal Microbiota-Inflammation-Cancer Axis. Front Immunol 2022;13:894445. [PMID: 35619716 DOI: 10.3389/fimmu.2022.894445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 126 |
Alkushi AG, Elazab ST, Abdelfattah-hassan A, Mahfouz H, Salem GA, Sheraiba NI, Mohamed EAA, Attia MS, El-shetry ES, Saleh AA, Elsawy NA, Ibrahim D. Multi-Strain-Probiotic-Loaded Nanoparticles Reduced Colon Inflammation and Orchestrated the Expressions of Tight Junction, NLRP3 Inflammasome and Caspase-1 Genes in DSS-Induced Colitis Model. Pharmaceutics 2022;14:1183. [DOI: 10.3390/pharmaceutics14061183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 127 |
De Sousa JFM, Paghdar S, Khan TM, Patel NP, Chandrasekaran S, Tsouklidis N. Stress and Inflammatory Bowel Disease: Clear Mind, Happy Colon. Cureus. [DOI: 10.7759/cureus.25006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 128 |
Shimodaira Y, Watanabe K, Iijima K. The risk of antibiotics and enterocolitis for the development of inflammatory bowel disease: a Japanese administrative database analysis. Sci Rep 2022;12:7604. [PMID: 35534662 DOI: 10.1038/s41598-022-11646-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 129 |
Aximujiang K, Kaheman K, Wushouer X, Wu G, Ahemaiti A, Yunusi K. Lactobacillus acidophilus and HKL Suspension Alleviates Ulcerative Colitis in Rats by Regulating Gut Microbiota, Suppressing TLR9, and Promoting Metabolism. Front Pharmacol 2022;13:859628. [DOI: 10.3389/fphar.2022.859628] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 130 |
Weiß F, Czichos C, Knobe L, Voges L, Bojarski C, Michel G, Fromm M, Krug SM. MarvelD3 Is Upregulated in Ulcerative Colitis and Has Attenuating Effects during Colitis Indirectly Stabilizing the Intestinal Barrier. Cells 2022;11:1541. [DOI: 10.3390/cells11091541] [Reference Citation Analysis]
|
| 131 |
Chen H, Fu T, Dan L, Chen X, Sun Y, Chen J, Wang X, Hesketh T. Meat consumption and all-cause mortality in 5763 patients with inflammatory bowel disease: A retrospective cohort study. EClinicalMedicine 2022;47:101406. [PMID: 35497068 DOI: 10.1016/j.eclinm.2022.101406] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 132 |
Gao S, Li Y, Wu D, Jiao N, Yang L, Zhao R, Xu Z, Chen W, Lin X, Cheng S, Zhu L, Lan P, Zhu R. IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC. Front Pharmacol 2022;13:869200. [PMID: 35462887 DOI: 10.3389/fphar.2022.869200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 133 |
Gill PA, Inniss S, Kumagai T, Rahman FZ, Smith AM. The Role of Diet and Gut Microbiota in Regulating Gastrointestinal and Inflammatory Disease. Front Immunol 2022;13:866059. [PMID: 35450067 DOI: 10.3389/fimmu.2022.866059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 134 |
Zangara MT, Ponti AK, Miller ND, Engelhart MJ, Ahern PP, Sangwan N, McDonald C. Maltodextrin Consumption Impairs the Intestinal Mucus Barrier and Accelerates Colitis Through Direct Actions on the Epithelium. Front Immunol 2022;13:841188. [PMID: 35359925 DOI: 10.3389/fimmu.2022.841188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 135 |
Wlazło M, Kierkuś J. Dual Biologic Therapy for the Treatment of Pediatric Inflammatory Bowel Disease: A Review of the Literature. JCM 2022;11:2004. [DOI: 10.3390/jcm11072004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 136 |
Nishikawa A, Tanaka K, Miyake Y, Nagata C, Furukawa S, Andoh A, Yokoyama T, Yoshimura N, Mori K, Ninomiya T, Yamamoto Y, Takeshita E, Ikeda Y, Saito M, Ohashi K, Imaeda H, Kakimoto K, Higuchi K, Nunoi H, Mizukami Y, Suzuki S, Hiraoka S, Okada H, Kawasaki K, Higashiyama M, Hokari R, Miura H, Miyake T, Kumagi T, Kato H, Hato N, Sayama K, Hiasa Y; Japan Ulcerative Colitis Study Group. Active and passive smoking and risk of ulcerative colitis: A case-control study in Japan. J Gastroenterol Hepatol 2022;37:653-9. [PMID: 34845747 DOI: 10.1111/jgh.15745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 137 |
Swier RM, Siebrasse A, Coscia E, Peery AF. Diet in Benign Colonic Disorders: A Narrative Review. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2022.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 138 |
Li M, Guo W, Dong Y, Wang W, Tian C, Zhang Z, Yu T, Zhou H, Gui Y, Xue K, Li J, Jiang F, Sarapultsev A, Wang H, Zhang G, Luo S, Fan H, Hu D. Beneficial Effects of Celastrol on Immune Balance by Modulating Gut Microbiota in Experimental Ulcerative Colitis Mice. Genomics Proteomics Bioinformatics 2022;20:288-303. [PMID: 35609771 DOI: 10.1016/j.gpb.2022.05.002] [Reference Citation Analysis]
|
| 139 |
Keefer L, Bedell A, Norton C, Hart AL. How Should Pain, Fatigue, and Emotional Wellness Be Incorporated Into Treatment Goals for Optimal Management of Inflammatory Bowel Disease? Gastroenterology 2022;162:1439-51. [PMID: 34995528 DOI: 10.1053/j.gastro.2021.08.060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 140 |
Amano T, Shinzaki S, Asakura A, Tashiro T, Tani M, Otake Y, Yoshihara T, Iwatani S, Yamada T, Sakakibara Y, Osugi N, Ishii S, Egawa S, Araki M, Arimoto Y, Nakahara M, Murayama Y, Kobayashi I, Kinoshita K, Ogawa H, Hiyama S, Shibukawa N, Komori M, Okuda Y, Kizu T, Yoshii S, Tsujii Y, Hayashi Y, Inoue T, Iijima H, Takehara T. Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease. Sci Rep 2022;12:5324. [PMID: 35351986 DOI: 10.1038/s41598-022-09455-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 141 |
He P, Yu L, Tian F, Zhang H, Chen W, Zhai Q. Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease. Adv Nutr 2022;13:1628-51. [PMID: 35348593 DOI: 10.1093/advances/nmac029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 142 |
Alkushi AG, Abdelfattah-Hassan A, Eldoumani H, Elazab ST, Mohamed SAM, Metwally AS, S El-Shetry E, Saleh AA, ElSawy NA, Ibrahim D. Probiotics-loaded nanoparticles attenuated colon inflammation, oxidative stress, and apoptosis in colitis. Sci Rep 2022;12:5116. [PMID: 35332200 DOI: 10.1038/s41598-022-08915-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 143 |
Mukhopadhyay S, Saha S, Chakraborty S, Prasad P, Ghosh A, Aich P. Differential colitis susceptibility of Th1- and Th2-biased mice: A multi-omics approach. PLoS ONE 2022;17:e0264400. [DOI: 10.1371/journal.pone.0264400] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 144 |
Wang Y, Li S, Gong J, Cao L, Xu D, Yu Q, Wang X, Chen Y. Perceived Stigma and Self-Efficacy of Patients With Inflammatory Bowel Disease-Related Stoma in China: A Cross-Sectional Study. Front Med (Lausanne) 2022;9:813367. [PMID: 35252252 DOI: 10.3389/fmed.2022.813367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 145 |
Hu Y, Ye Z, She Y, Li L, Wu M, Qin K, Li Y, He H, Hu Z, Yang M, Lu F, Ye Q. Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Front Pharmacol 2022;13:844961. [DOI: 10.3389/fphar.2022.844961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 146 |
Bao C, Wu L, Wang D, Chen L, Jin X, Shi Y, Li G, Zhang J, Zeng X, Chen J, Liu H, Wu H. Acupuncture improves the symptoms, intestinal microbiota, and inflammation of patients with mild to moderate Crohn's disease: A randomized controlled trial. EClinicalMedicine 2022;45:101300. [PMID: 35198926 DOI: 10.1016/j.eclinm.2022.101300] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 147 |
Zhang B, Xu Y, Zhao C, Zhang Y, Lv H, Ji X, Wang J, Pang W, Wang X, Wang S. Protective effects of bioactive peptides in foxtail millet protein hydrolysates against experimental colitis in mice. Food Funct 2022. [PMID: 35166735 DOI: 10.1039/d1fo02482e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 148 |
Salama RI, Ahmed MH. Can Fecal Calprotectin Reflect Your Colonic Status? Journal of Coloproctology. [DOI: 10.1055/s-0041-1739351] [Reference Citation Analysis]
|
| 149 |
Al Saedi A, Sharma S, Bani Hassan E, Chen L, Ghasem-Zadeh A, Hassanzadeganroudsari M, Gooi JH, Stavely R, Eri R, Miao D, Nurgali K, Duque G. Characterization of Skeletal Phenotype and Associated Mechanisms With Chronic Intestinal Inflammation in the Winnie Mouse Model of Spontaneous Chronic Colitis. Inflamm Bowel Dis 2022;28:259-72. [PMID: 34347076 DOI: 10.1093/ibd/izab174] [Reference Citation Analysis]
|
| 150 |
Zhao M, Feng R, Ben-Horin S, Zhuang X, Tian Z, Li X, Ma R, Mao R, Qiu Y, Chen M. Systematic review with meta-analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations. Aliment Pharmacol Ther 2022;55:266-76. [PMID: 34820868 DOI: 10.1111/apt.16703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 151 |
Furuya Y, Fukai K, Nakazawa S, Kojimahara N, Hoshi K, Toyota A, Tatemichi M. Occupational physical activity differentially affects the risk for developing later-onset Crohn's disease and ulcerative colitis among middle-aged and older populations. Scand J Gastroenterol 2022;57:206-13. [PMID: 34762552 DOI: 10.1080/00365521.2021.1999495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 152 |
Wang X, Wan J, Wang M, Zhang Y, Wu K, Yang F. Multiple sclerosis and inflammatory bowel disease: A systematic review and meta‐analysis. Ann Clin Transl Neurol. [DOI: 10.1002/acn3.51495] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 153 |
Siddiqui N, Bhavana P, Sarvani V. Impact of Metabolic Regulation in Understanding the Status of Human Health and Diseases: A Review. Int J Pharma Bio Sci 2022;12:19-31. [DOI: 10.22376/ijpbs/lpr.2022.12.1.l19-31] [Reference Citation Analysis]
|
| 154 |
Zhao J, Ma Z, Zheng H, Huang Y, Wu L, Wu H, Shi Y, Liu H, Liu Y. Effects of Herb-Partitioned Moxibustion on Autophagy and Immune Activity in the Colon Tissue of Rats with Crohn’s Disease. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-12. [DOI: 10.1155/2022/3534874] [Reference Citation Analysis]
|
| 155 |
Bilotta S, Arbogast J, Schart N, Frei M, Lorentz A. Resveratrol Treatment Prevents Increase of Mast Cells in Both Murine OVA Enteritis and IL-10-/- Colitis. Int J Mol Sci 2022;23:1213. [PMID: 35163137 DOI: 10.3390/ijms23031213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 156 |
Kaplan GG, Underwood FE, Coward S, Agrawal M, Ungaro RC, Brenner EJ, Gearry RB, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Steinwurz F, Zhang X, Kappelman MD, Colombel JF. The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis. Inflamm Bowel Dis 2022;28:1687-95. [PMID: 35032167 DOI: 10.1093/ibd/izab339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 157 |
Hryhorowicz S, Kaczmarek-Ryś M, Zielińska A, Scott RJ, Słomski R, Pławski A. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review. Front Immunol 2021;12:790803. [PMID: 35003109 DOI: 10.3389/fimmu.2021.790803] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 158 |
Kum DJ, Bang KS. Body image, self-esteem, and quality of life in children and adolescents with inflammatory bowel disease in a tertiary hospital in South Korea. Child Health Nurs Res 2021;27:181-9. [PMID: 35004508 DOI: 10.4094/chnr.2021.27.2.181] [Reference Citation Analysis]
|
| 159 |
Gong L, Xiao J, Yi J, Xiao J, Lu F, Liu X. Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling. Inflamm Bowel Dis 2022;28:96-108. [PMID: 34106260 DOI: 10.1093/ibd/izab132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 160 |
Adachi K, Ishizawa M, Uno S, Kubota H, Henmi T, Koshinaga T, Makishima M, Sakurai K. Oral benzo[a]pyrene administration attenuates dextran sulfate sodium-induced colitis in mice. Chem Biol Interact 2022;353:109802. [PMID: 34998820 DOI: 10.1016/j.cbi.2022.109802] [Reference Citation Analysis]
|
| 161 |
Kwak MJ, Ha DJ, Choi YS, Lee H, Whang KY. Protective and restorative effects of sophorolipid on intestinal dystrophy in dextran sulfate sodium-induced colitis mouse model. Food Funct 2021. [PMID: 34874374 DOI: 10.1039/d1fo03109k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 162 |
Rao A, Gokhale R. Ulcerative Colitis. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2022. [DOI: 10.1007/978-3-030-80068-0_30] [Reference Citation Analysis]
|
| 163 |
Borowitz SM. The epidemiology of inflammatory bowel disease: Clues to pathogenesis? Front Pediatr 2022;10:1103713. [PMID: 36733765 DOI: 10.3389/fped.2022.1103713] [Reference Citation Analysis]
|
| 164 |
Sarmento A, Simões CD. Gut Microbiota Dysbiosis and Chronic Intestinal Inflammation. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00057-7] [Reference Citation Analysis]
|
| 165 |
Rosen MJ. New Role for Fatty Acid Receptor Regulation of Immune Cells to Control Intestinal Inflammation. Gastroenterology 2022;162:40-2. [PMID: 34672998 DOI: 10.1053/j.gastro.2021.09.072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 166 |
Zou M, Zeng QS, Nie J, Yang JH, Luo ZY, Gan HT. The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe? Front Immunol 2021;12:769167. [PMID: 34956195 DOI: 10.3389/fimmu.2021.769167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 167 |
Chen JA, Ma H, Liu Z, Tian J, Lu S, Fang W, Ze S, Lu W, Xie Q, Huang J, Wang Y. Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ-t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease. J Med Chem 2021. [PMID: 34957834 DOI: 10.1021/acs.jmedchem.1c01746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 168 |
Lyu S, Pan F, Ge H, Yang Q, Duan X, Feng M, Liu X, Zhang T, Liu J. Fermented egg-milk beverage alleviates dextran sulfate sodium-induced colitis in mice through the modulation of intestinal flora and short-chain fatty acids. Food Funct 2021. [PMID: 34935826 DOI: 10.1039/d1fo03040j] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 169 |
Chen R, Zheng J, Li L, Li C, Chao K, Zeng Z, Chen M, Zhang S. Metabolomics facilitate the personalized management in inflammatory bowel disease. Therap Adv Gastroenterol 2021;14:17562848211064489. [PMID: 34987610 DOI: 10.1177/17562848211064489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 170 |
Wnorowski A, Wnorowska S, Kurzepa J, Parada-Turska J. Alterations in Kynurenine and NAD+ Salvage Pathways during the Successful Treatment of Inflammatory Bowel Disease Suggest HCAR3 and NNMT as Potential Drug Targets. Int J Mol Sci 2021;22:13497. [PMID: 34948292 DOI: 10.3390/ijms222413497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 171 |
Fucilini LMP, Genaro LM, Sousa DCE, Coy CSR, Leal RF, Ayrizono MLS. EPIDEMIOLOGICAL PROFILE AND CLINICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASES IN A BRAZILIAN REFERRAL CENTER. Arq Gastroenterol 2021;58:483-90. [PMID: 34909854 DOI: 10.1590/S0004-2803.202100000-87] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 172 |
Gan J, Liu Y, Sun L, Ma W, Chen G, Zhao C, Wen L, Zhao Y, Sun L. Orally administrated nucleotide-delivery particles from microfluidics for inflammatory bowel disease treatment. Applied Materials Today 2021;25:101231. [DOI: 10.1016/j.apmt.2021.101231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 173 |
Yao J, Gao R, Luo M, Li D, Guo L, Yu Z, Xiong F, Wei C, Wu B, Xu Z, Zhang D, Wang J, Wang L. Long noncoding RNA KIF9-AS1 promotes cell apoptosis by targeting the microRNA-148a-3p/suppressor of cytokine signaling axis in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2021;33:e922-32. [PMID: 34750325 DOI: 10.1097/MEG.0000000000002309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 174 |
Jiang Q, Xu Q, Wang Y, Li P, Zhang Y, Wang Y, Sun J, Zhang T, He Z. Modulation of Naturally Occurring Linear Dipeptide Chirality to Reduce the Affinity for Oligopeptide Transporter 1 and Increase Intestinal Stability for an Enhanced Colon-Targeting Effect in the Treatment of Inflammatory Bowel Disease: An Application of trans-4-l-Hydroxyprolyl-l-serine. J Med Chem 2021. [PMID: 34842428 DOI: 10.1021/acs.jmedchem.1c01276] [Reference Citation Analysis]
|
| 175 |
Sun Y, Xie R, Li L, Jin G, Zhou B, Huang H, Li M, Yang Y, Liu X, Cao X, Wang B, Liu W, Jiang K, Cao H. Prenatal Maternal Stress Exacerbates Experimental Colitis of Offspring in Adulthood. Front Immunol 2021;12:700995. [PMID: 34804005 DOI: 10.3389/fimmu.2021.700995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 176 |
Xu C, Liu Z, Xiao J. Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease. Int J Mol Sci 2021;22:12403. [PMID: 34830285 DOI: 10.3390/ijms222212403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 177 |
Najafimehr H, Aghdaei HA, Pourhoseingholi MA, Shalmani HM, Vahedian-Azimi A, Kroh M, Zali MR, Sahebkar A. A Systematic Review and Meta-Analysis on the Association between Inflammatory Bowel Disease Family History and Colorectal Cancer. Gastroenterol Res Pract 2021;2021:4874459. [PMID: 34725546 DOI: 10.1155/2021/4874459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 178 |
Acar B, Gümüş E, Özcan-Bulut S, Özşin-Özler C, Boyraz MS, Tan Ç, Yaz I, Özbek B, Cagdas D, Saltık-Temizel İN, Demir H, Özen H, Karabulut E, Tezcan İ, Yüce A, Berker E. Cytokine profile in serum and gingival crevicular fluid of children with inflammatory bowel disease: A case-control study. J Periodontol 2021. [PMID: 34730850 DOI: 10.1002/JPER.21-0514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 179 |
Mo Q, Liu T, Fu A, Ruan S, Zhong H, Tang J, Zhao M, Li Y, Zhu S, Cai H, Feng F. Novel Gut Microbiota Patterns Involved in the Attenuation of Dextran Sodium Sulfate-Induced Mouse Colitis Mediated by Glycerol Monolaurate via Inducing Anti-inflammatory Responses. mBio 2021;12:e0214821. [PMID: 34634946 DOI: 10.1128/mBio.02148-21] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 180 |
Sarbagili-Shabat C, Albenberg L, Van Limbergen J, Pressman N, Otley A, Yaakov M, Wine E, Weiner D, Levine A. A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study. Nutrients 2021;13:3736. [PMID: 34835992 DOI: 10.3390/nu13113736] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 181 |
Fu W, Fu H, Ye W, Han Y, Liu X, Zhu S, Li H, Tang R, Wang Q. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: A meta-analysis. Int Immunopharmacol 2021;101:108235. [PMID: 34678692 DOI: 10.1016/j.intimp.2021.108235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 182 |
Cao Y, Gao J, Zhang L, Qin N, Zhu B, Xia X. Jellyfish skin polysaccharides enhance intestinal barrier function and modulate the gut microbiota in mice with DSS-induced colitis. Food Funct 2021;12:10121-35. [PMID: 34528649 DOI: 10.1039/d1fo02001c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 183 |
Lu Y, Chen J, He X, Xu S, Chen YE, Gao J, Hou S. Combined Administration of Vitamin D3 and Geniposide Is Less Effective than Single Use of Vitamin D3 or Geniposide in the Treatment of Ulcerative Colitis. Front Pharmacol 2021;12:714065. [PMID: 34650431 DOI: 10.3389/fphar.2021.714065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 184 |
Mitsuro Chiba, Norikazu Morita, Akira Nakamura, Keisuke Tsuji, Emiko Harashima. Increased Incidence of Inflammatory Bowel Disease in Association with Dietary Transition (Westernization) in Japan. JMA J 2021;4. [PMID: 34796289 DOI: 10.31662/jmaj.2021-0038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 185 |
Piovani D, Pansieri C, Kotha SRR, Piazza AC, Comberg CL, Peyrin-Biroulet L, Danese S, Bonovas S. Ethnic Differences in the Smoking-related Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis 2021;15:1658-78. [PMID: 33721889 DOI: 10.1093/ecco-jcc/jjab047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 186 |
Kriaa A, Jablaoui A, Rhimi S, Soussou S, Mkaouar H, Mariaule V, Gruba N, Gargouri A, Maguin E, Lesner A, Rhimi M. SP-1, a Serine Protease from the Gut Microbiota, Influences Colitis and Drives Intestinal Dysbiosis in Mice. Cells 2021;10:2658. [PMID: 34685638 DOI: 10.3390/cells10102658] [Reference Citation Analysis]
|
| 187 |
Wang N, Wang S, Xu B, Liu F, Huo G, Li B. Alleviation Effects of Bifidobacterium animalis subsp. lactis XLTG11 on Dextran Sulfate Sodium-Induced Colitis in Mice. Microorganisms 2021;9:2093. [PMID: 34683415 DOI: 10.3390/microorganisms9102093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 188 |
Granström AL, Ludvigsson JF, Wester T. Clinical characteristics and validation of diagnosis in individuals with Hirschsprung disease and inflammatory bowel disease. J Pediatr Surg 2021;56:1799-802. [PMID: 33276971 DOI: 10.1016/j.jpedsurg.2020.11.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 189 |
Soh H, Lee HJ, Han K, Park S, Hong SW, Moon JM, Kang EA, Lee J, Chun J, Im JP, Kim JS. Atopic Diseases Are Associated With Development of Inflammatory Bowel Diseases in Korea: A Nationwide Population-based Study. Clin Gastroenterol Hepatol 2021;19:2072-2081.e6. [PMID: 32712393 DOI: 10.1016/j.cgh.2020.07.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 190 |
Chen L, Wang J, Yi J, Liu Y, Yu Z, Chen S, Liu X. Increased mucin-degrading bacteria by high protein diet leads to thinner mucus layer and aggravates experimental colitis. J Gastroenterol Hepatol 2021;36:2864-74. [PMID: 34050560 DOI: 10.1111/jgh.15562] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 191 |
Ho SW, El-Nezami H, Corke H, Ho CS, Shah NP. L-citrulline enriched fermented milk with Lactobacillus helveticus attenuates dextran sulfate sodium (DSS) induced colitis in mice. J Nutr Biochem 2022;99:108858. [PMID: 34587540 DOI: 10.1016/j.jnutbio.2021.108858] [Reference Citation Analysis]
|
| 192 |
Li M, Guo W, Dong Y, Wang W, Tian C, Zhang Z, Yu T, Zhou H, Gui Y, Xue K, Li J, Jiang F, Sarapultsev A, Luo S, Fan H, Hu D. Beneficial Effects of Celastrol on Immune Balance by Modulating Gut Microbiota in Dextran Sodium Sulfate-Induced Ulcerative Colitis.. [DOI: 10.1101/2021.09.28.462065] [Reference Citation Analysis]
|
| 193 |
Chen ZA, Tian H, Yao DM, Zhang Y, Feng ZJ, Yang CJ. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Front Oncol 2021;11:738477. [PMID: 34568075 DOI: 10.3389/fonc.2021.738477] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 194 |
Fernández-Tomé S, Ortega Moreno L, Chaparro M, Gisbert JP. Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:10224. [PMID: 34638564 DOI: 10.3390/ijms221910224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 195 |
Xie XT, Zheng LX, Duan HM, Liu Y, Chen XQ, Cheong KL. Structural characteristics of Gracilaria lemaneiformis oligosaccharides and their alleviation of dextran sulphate sodium-induced colitis by modulating the gut microbiota and intestinal metabolites in mice. Food Funct 2021;12:8635-46. [PMID: 34346464 DOI: 10.1039/d1fo01201k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 196 |
Wu D, Chen D, Shi W, Liu W, Zhou W, Qian J. Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA. Can J Gastroenterol Hepatol 2021;2021:9936932. [PMID: 34545326 DOI: 10.1155/2021/9936932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 197 |
Yang M, Gu Y, Li L, Liu T, Song X, Sun Y, Cao X, Wang B, Jiang K, Cao H. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside. Nutrients 2021;13:3143. [PMID: 34579027 DOI: 10.3390/nu13093143] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 198 |
Rocha R, de J Santos G, Santana G. Influence of nutritional status in the postoperative period of patients with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2021; 12(5): 90-99 [PMID: 34616585 DOI: 10.4292/wjgpt.v12.i5.90] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 199 |
Takagi T, Uchiyama K, Kajiwara-Kubota M, Kashiwagi S, Toyokawa Y, Hotta Y, Tanaka M, Inoue K, Dohi O, Yoshida N, Kamada K, Ishikawa T, Konishi H, Kishimoto M, Yagi N, Naito Y, Itoh Y. The efficacy of linked color imaging for the endoscopic diagnosis of mucosal healing in quiescent ulcerative colitis. J Gastroenterol Hepatol 2021;36:2448-54. [PMID: 33710655 DOI: 10.1111/jgh.15489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 200 |
Ahola Kohut S, Forgeron P, Mcmurtry M, Weiser N, Iuliano A, Stinson J. Resilience Factors in Paediatric Inflammatory Bowel Disease: Health Care Provider, Parent and Youth Perspectives. J Child Fam Stud 2021;30:2250-2263. [DOI: 10.1007/s10826-021-02040-z] [Reference Citation Analysis]
|
| 201 |
Liu P, Gao C, Chen H, Vong CT, Wu X, Tang X, Wang S, Wang Y. Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies. Acta Pharm Sin B 2021;11:2798-818. [PMID: 34589398 DOI: 10.1016/j.apsb.2020.11.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 202 |
Fernandes SA, Rossoni C, Koch VW, Imbrizi M, Evangelista-Poderoso R, Pinto LP, Magro DO. Phase angle through electrical bioimpedance as a predictor of cellularity in inflammatory bowel disease. Artif Intell Gastroenterol 2021; 2(4): 111-123 [DOI: 10.35712/aig.v2.i4.111] [Reference Citation Analysis]
|
| 203 |
Zhou YF, Sun N, Cheng SR, Deng XD, Ye XY, Li ZJ, Zhou J, Xu GX, Qu YZ, Huang LY, Sun RR, Liang FR. Effectiveness and safety of acupuncture therapy for inflammatory bowel disease: a protocol of systematic review and meta-analysis. BMJ Open 2021;11:e045090. [PMID: 34429304 DOI: 10.1136/bmjopen-2020-045090] [Reference Citation Analysis]
|
| 204 |
Pan S, Hong F, Li L, Guo Y, Qiao X, Zhang J, Xu P, Zhai Y. Melatonin Attenuates Dextran Sodium Sulfate Induced Colitis in Obese Mice. Pharmaceuticals (Basel) 2021;14:822. [PMID: 34451919 DOI: 10.3390/ph14080822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 205 |
Basso D, Padoan A, D'Incà R, Arrigoni G, Scapellato ML, Contran N, Franchin C, Lorenzon G, Mescoli C, Moz S, Bozzato D, Rugge M, Plebani M. Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis. Clin Chem Lab Med 2020;58:968-79. [PMID: 32229654 DOI: 10.1515/cclm-2019-1125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 206 |
Weingarden AR, Rubin SJS, Gubatan J. Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease. World J Gastrointest Oncol 2021; 13(8): 772-798 [PMID: 34457186 DOI: 10.4251/wjgo.v13.i8.772] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 207 |
Xu J, Liu S, Cui Z, Wang X, Ning T, Wang T, Zhang N, Xie S, Min L, Zhang S, Liang C, Zhu S. Ferrostatin-1 alleviated TNBS induced colitis via the inhibition of ferroptosis. Biochem Biophys Res Commun 2021;573:48-54. [PMID: 34388454 DOI: 10.1016/j.bbrc.2021.08.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 208 |
Peters V, Spooren CEGM, Pierik MJ, Weersma RK, van Dullemen HM, Festen EAM, Visschedijk MC, Masclee AAM, Hendrix EMB, Almeida RJ, Perenboom CWM, Feskens EJM, Dijkstra G, Campmans-Kuijpers MJE, Jonkers DMAE. Dietary Intake Pattern is Associated with Occurrence of Flares in IBD Patients. J Crohns Colitis 2021;15:1305-15. [PMID: 33439251 DOI: 10.1093/ecco-jcc/jjab008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 209 |
Qin Y, Zhao R, Qin H, Chen L, Chen H, Zhao Y, Nie G. Colonic mucus-accumulating tungsten oxide nanoparticles improve the colitis therapy by targeting Enterobacteriaceae. Nano Today 2021;39:101234. [DOI: 10.1016/j.nantod.2021.101234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 210 |
Goh K. Ulcerative colltis in the older patient‐ a treatment conundrum. JGH Open 2021;5:841-841. [DOI: 10.1002/jgh3.12620] [Reference Citation Analysis]
|
| 211 |
Mannino G, Chinigò G, Serio G, Genova T, Gentile C, Munaron L, Bertea CM. Proanthocyanidins and Where to Find Them: A Meta-Analytic Approach to Investigate Their Chemistry, Biosynthesis, Distribution, and Effect on Human Health. Antioxidants (Basel) 2021;10:1229. [PMID: 34439477 DOI: 10.3390/antiox10081229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 212 |
Liu J, Liu J, Tong X, Peng W, Wei S, Sun T, Wang Y, Zhang B, Li W. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis. Drug Des Devel Ther 2021;15:3255-76. [PMID: 34349502 DOI: 10.2147/DDDT.S319786] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 213 |
Wang X, Yuan X, Su Y, Hu J, Ji Q, Fu S, Li R, Hu L, Dai C. Targeting Purinergic Receptor P2RX1 Modulates Intestinal Microbiota and Alleviates Inflammation in Colitis. Front Immunol 2021;12:696766. [PMID: 34354708 DOI: 10.3389/fimmu.2021.696766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 214 |
Bicbavova GR, Livzan MA, Lozinskaya MY. Pathogenetic factors of ulcerative colitis: mainstream for 2020. Bûll sib med 2021;20:130-138. [DOI: 10.20538/1682-0363-2021-2-130-138] [Reference Citation Analysis]
|
| 215 |
Chen ZA, Sun YF, Wang QX, Ma HH, Ma ZZ, Yang CJ. Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Ulcerative Colitis. Front Genet 2021;12:697514. [PMID: 34306038 DOI: 10.3389/fgene.2021.697514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 216 |
Lim Z, Welman CJ, Raymond W, Thin L. The Effect of Adiposity on Anti-Tumor Necrosis Factor-Alpha Levels and Loss of Response in Crohn's Disease Patients. Clin Transl Gastroenterol 2020;11:e00233. [PMID: 33094963 DOI: 10.14309/ctg.0000000000000233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 217 |
Xu M, Shen Y, Cen M, Zhu Y, Cheng F, Tang L, Zheng X, Kim JJ, Dai N, Hu W. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice. J Crohns Colitis 2021;15:1197-210. [PMID: 33417675 DOI: 10.1093/ecco-jcc/jjab003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 218 |
Yu L, Zhao D, Nian Y, Li C. Casein-fed mice showed faster recovery from DSS-induced colitis than chicken-protein-fed mice. Food Funct 2021;12:5806-20. [PMID: 34047734 DOI: 10.1039/d1fo00659b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 219 |
Liu C, Hua H, Zhu H, Cheng Y, Guo Y, Yao W, Qian H. Aloe polysaccharides ameliorate acute colitis in mice via Nrf2/HO-1 signaling pathway and short-chain fatty acids metabolism. Int J Biol Macromol 2021;185:804-12. [PMID: 34229016 DOI: 10.1016/j.ijbiomac.2021.07.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 220 |
Rodríguez-Lago I, Agirre U, Intxaurza N, Cantero D, Cabriada JL, Barreiro-de Acosta M. Increased use of healthcare resources during the preclinical period of inflammatory bowel disease. Dig Liver Dis 2021;53:927-30. [PMID: 33994123 DOI: 10.1016/j.dld.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 221 |
Ameen MSM, Malviya R, Porwal O, Anwar ET, Pant S, Sharma A. Novel Strategies and Model Studies for Colon Targeted Drug Delivery. DDL 2021;11:156-163. [DOI: 10.2174/2210303111666210118141406] [Reference Citation Analysis]
|
| 222 |
Yang ZH, Liu F, Zhu XR, Suo FY, Jia ZJ, Yao SK. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroenterol 2021; 27(24): 3609-3629 [PMID: 34239273 DOI: 10.3748/wjg.v27.i24.3609] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 223 |
Zhu R, He P, Liu Z, Liu N, Miao Y, Yu C, Zhu L. Editorial: Microbiome in IBD: From Composition to Therapy. Front Pharmacol 2021;12:721992. [PMID: 34248651 DOI: 10.3389/fphar.2021.721992] [Reference Citation Analysis]
|
| 224 |
Khan S, Waliullah S, Godfrey V, Khan MAW, Ramachandran RA, Cantarel BL, Behrendt C, Peng L, Hooper LV, Zaki H. Dietary simple sugars alter microbial ecology in the gut and promote colitis in mice. Sci Transl Med 2020;12:eaay6218. [PMID: 33115951 DOI: 10.1126/scitranslmed.aay6218] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 41.5] [Reference Citation Analysis]
|
| 225 |
Li CM, Chen Z. Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation. Front Cell Dev Biol 2021;9:664305. [PMID: 34235145 DOI: 10.3389/fcell.2021.664305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 226 |
Jia PP, Junaid M, Wen PP, Yang YF, Li WG, Yang XG, Pei DS. Role of germ-free animal models in understanding interactions of gut microbiota to host and environmental health: A special reference to zebrafish. Environ Pollut 2021;279:116925. [PMID: 33744636 DOI: 10.1016/j.envpol.2021.116925] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 227 |
Chen LM, Bao CH, Wu Y, Liang SH, Wang D, Wu LY, Huang Y, Liu HR, Wu HG. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. J Neuroinflammation 2021;18:135. [PMID: 34127024 DOI: 10.1186/s12974-021-02175-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 228 |
Sun Y, Zhang Z, Zheng CQ, Sang LX. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review. World J Gastroenterol 2021; 27(22): 2963-2978 [PMID: 34168401 DOI: 10.3748/wjg.v27.i22.2963] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 229 |
Gu FL, Huang RS, He XM, Chen NF, Han BX, Deng H. Dendrobium huoshanense Polysaccharides Prevent Inflammatory Response of Ulcerative Colitis Rat through Inhibiting the NF-κB Signaling Pathway. Chem Biodivers 2021;18:e2100130. [PMID: 34080308 DOI: 10.1002/cbdv.202100130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 230 |
Chang TE, Luo JC, Yang UC, Huang YH, Hou MC, Lee FY. Fecal microbiota profile in patients with inflammatory bowel disease in Taiwan. J Chin Med Assoc 2021;84:580-7. [PMID: 33871395 DOI: 10.1097/JCMA.0000000000000532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 231 |
Bernstein CN, Kuenzig ME, Coward S, Nugent Z, Nasr A, El-Matary W, Singh H, Kaplan GG, Benchimol EI. Increased Incidence of Inflammatory Bowel Disease After Hirschsprung Disease: A Population-based Cohort Study. J Pediatr 2021;233:98-104.e2. [PMID: 33545193 DOI: 10.1016/j.jpeds.2021.01.060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 232 |
Kaenkumchorn T, Musburger B, Suskind DL. Contemporary Dietary Therapies in Inflammatory Bowel Disease. Curr Treat Options Peds 2021;7:33-45. [DOI: 10.1007/s40746-021-00220-z] [Reference Citation Analysis]
|
| 233 |
Lucius K. Nutritional and Botanical Approaches for Inflammatory Bowel Disease. Alternative and Complementary Therapies 2021;27:141-151. [DOI: 10.1089/act.2021.29331.klu] [Reference Citation Analysis]
|
| 234 |
Song S, Bai M, Ling Z, Lin Y, Wang S, Chen Y. Intermittent administration of a fasting-mimicking diet reduces intestinal inflammation and promotes repair to ameliorate inflammatory bowel disease in mice. J Nutr Biochem 2021;96:108785. [PMID: 34087411 DOI: 10.1016/j.jnutbio.2021.108785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 235 |
Tulumović E, Salkić N, Tulumović D. Inflammatory bowel disease in Tuzla Canton, Bosnia-Herzegovina: A prospective 10-year follow-up. World J Gastroenterol 2021; 27(20): 2630-2642 [PMID: 34092980 DOI: 10.3748/wjg.v27.i20.2630] [Reference Citation Analysis]
|
| 236 |
Chen Y, Liu M, Wang W, Cai W, Song W, Li L, Lin GN. Loss of Setd2 associates with aberrant microRNA expression and contributes to inflammatory bowel disease progression in mice. Genomics 2021;113:2441-54. [PMID: 34052319 DOI: 10.1016/j.ygeno.2021.05.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 237 |
Peña-Sánchez JN, Osei JA, Marques Santos JD, Jennings D, Andkhoie M, Brass C, Bukassa-Kazadi G, Lu X, Johnson-Jennings M, Porter L, Porter R, Quintin CL, Sanderson R, Teucher U, Fowler S. Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province. Inflamm Bowel Dis 2022;28:514-22. [PMID: 34037223 DOI: 10.1093/ibd/izab096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 238 |
Varbobitis I, Kokkotis G, Gizis M, Perlepe N, Laoudi E, Bletsa M, Bekiari D, Koutsounas I, Kounadis G, Xourafas V, Lagou S, Kolios G, Papakonstantinou I, Bamias G. The IBD-F Patient Self-Assessment Scale Accurately Depicts the Level of Fatigue and Predicts a Negative Effect on the Quality of Life of Patients With IBD in Clinical Remission. Inflamm Bowel Dis 2021;27:826-35. [PMID: 32766770 DOI: 10.1093/ibd/izaa201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 239 |
Wang K, Ding Y, Xu C, Hao M, Li H, Ding L. Cldn-7 deficiency promotes experimental colitis and associated carcinogenesis by regulating intestinal epithelial integrity. Oncoimmunology 2021;10:1923910. [PMID: 34026335 DOI: 10.1080/2162402X.2021.1923910] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 240 |
Popov J, Farbod Y, Chauhan U, Kalantar M, Hill L, Armstrong D, Halder S, Marshall JK, Moayyedi P, Kaasalainen S. Patients' Experiences and Challenges in Living with Inflammatory Bowel Disease: A Qualitative Approach. Clin Exp Gastroenterol 2021;14:123-31. [PMID: 33953591 DOI: 10.2147/CEG.S303688] [Reference Citation Analysis]
|
| 241 |
Yeung AWK. Structural and functional changes in the brain of patients with Crohn's disease: an activation likelihood estimation meta-analysis. Brain Imaging Behav 2021;15:807-18. [PMID: 32333318 DOI: 10.1007/s11682-020-00291-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 242 |
Li C, Wu G, Zhao H, Dong N, Wu B, Chen Y, Lu Q. Natural-Derived Polysaccharides From Plants, Mushrooms, and Seaweeds for the Treatment of Inflammatory Bowel Disease. Front Pharmacol 2021;12:651813. [PMID: 33981232 DOI: 10.3389/fphar.2021.651813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 243 |
Lirhus SS, Høivik ML, Moum B, Anisdahl K, Melberg HO. Incidence and Prevalence of Inflammatory Bowel Disease in Norway and the Impact of Different Case Definitions: A Nationwide Registry Study. Clin Epidemiol 2021;13:287-94. [PMID: 33935519 DOI: 10.2147/CLEP.S303797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 244 |
Li J, Ren S, Li M, Bi J, Yang G, Li E. Paeoniflorin protects against dextran sulfate sodium (DSS)-induced colitis in mice through inhibition of inflammation and eosinophil infiltration. Int Immunopharmacol 2021;97:107667. [PMID: 33887576 DOI: 10.1016/j.intimp.2021.107667] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 245 |
Shen H, Zhang S, Zhao W, Ren S, Ke X, Gu Q, Tang Z, Xie J, Chen S, Chen Y, Zou J, Zhang L, Shen Z, Zheng K, Liu Y, Gu P, Cheng J, Hu J, Zhu L. Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis. Biomed Pharmacother 2021;139:111580. [PMID: 33857914 DOI: 10.1016/j.biopha.2021.111580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 246 |
Wen S, Zhong Z, He L, Zhao D, Chen X, Mi H, Liu F. Network pharmacology dissection of multiscale mechanisms for jiaoqi powder in treating ulcerative colitis. J Ethnopharmacol 2021;275:114109. [PMID: 33845143 DOI: 10.1016/j.jep.2021.114109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 247 |
Hu JE, Weiß F, Bojarski C, Branchi F, Schulzke JD, Fromm M, Krug SM. Expression of tricellular tight junction proteins and the paracellular macromolecule barrier are recovered in remission of ulcerative colitis. BMC Gastroenterol 2021;21:141. [PMID: 33789594 DOI: 10.1186/s12876-021-01723-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 248 |
Liu S, Xu A, Gao Y, Xie Y, Liu Z, Sun M, Mao H, Wang X. Graphene oxide exacerbates dextran sodium sulfate-induced colitis via ROS/AMPK/p53 signaling to mediate apoptosis. J Nanobiotechnology 2021;19:85. [PMID: 33766052 DOI: 10.1186/s12951-021-00832-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 249 |
Huang G, Wang Z, Wu G, Zhang R, Dong L, Huang F, Zhang M, Su D. Lychee (Litchi chinensis Sonn.) Pulp Phenolics Activate the Short-Chain Fatty Acid-Free Fatty Acid Receptor Anti-inflammatory Pathway by Regulating Microbiota and Mitigate Intestinal Barrier Damage in Dextran Sulfate Sodium-Induced Colitis in Mice. J Agric Food Chem 2021;69:3326-39. [PMID: 33533603 DOI: 10.1021/acs.jafc.0c07407] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 250 |
Ma S, Qian C, Li N, Fang Z, Zhao J, Zhang H, Chen W, Liu Z, Lu W. Protein diets with the role of immune and gut microbial regulation alleviate DSS-induced chronic ulcerative colitis. Food Sci Nutr 2021;9:1259-70. [PMID: 33747442 DOI: 10.1002/fsn3.1914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 251 |
Nishiguchi R, Basu S, Staab HA, Ito N, Zhou XK, Wang H, Ha T, Johncilla M, Yantiss RK, Montrose DC, Dannenberg AJ. Dietary interventions to prevent high-fructose diet-associated worsening of colitis and colitis-associated tumorigenesis in mice. Carcinogenesis 2021;42:842-52. [PMID: 33513602 DOI: 10.1093/carcin/bgab007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 252 |
Jin G, Tang Q, Ma J, Liu X, Zhou B, Sun Y, Pang X, Guo Z, Xie R, Liu T, Wang B, Cao H. Maternal Emulsifier P80 Intake Induces Gut Dysbiosis in Offspring and Increases Their Susceptibility to Colitis in Adulthood. mSystems 2021;6:e01337-20. [PMID: 33727402 DOI: 10.1128/mSystems.01337-20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 253 |
Yu T, Chu S, Liu X, Li J, Chen Q, Xu M, Wu H, Li M, Dong Y, Zhu F, Zhou H, Hu D, Fan H. Extracellular vesicles derived from EphB2-overexpressing bone marrow mesenchymal stem cells ameliorate DSS-induced colitis by modulating immune balance. Stem Cell Res Ther 2021;12:181. [PMID: 33722292 DOI: 10.1186/s13287-021-02232-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 254 |
Ding ZH, Xu XP, Wang TR, Liang X, Ran ZH, Lu H. The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study. PLoS One 2021;16:e0248427. [PMID: 33711050 DOI: 10.1371/journal.pone.0248427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 255 |
Zeng W, He D, Xing Y, Liu J, Su N, Zhang C, Wang Y, Xing X. Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review. Food Science and Human Wellness 2021;10:119-30. [DOI: 10.1016/j.fshw.2021.02.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 256 |
Manandhar I, Alimadadi A, Aryal S, Munroe PB, Joe B, Cheng X. Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol 2021;320:G328-37. [PMID: 33439104 DOI: 10.1152/ajpgi.00360.2020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 257 |
Feng D, Yang Y, Wang Z, Wei W, Li L. Inflammatory bowel disease and risk of urinary cancers: a systematic review and pooled analysis of population-based studies. Transl Androl Urol 2021;10:1332-41. [PMID: 33850767 DOI: 10.21037/tau-20-1358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 258 |
Arunachalam K, Damazo AS, Macho A, Matchado MS, Pavan E, Figueiredo FF, Oliveira DM, Duckworth CA, Thangaraj P, Leonti M, Martins DTO. Canthin-6-one ameliorates TNBS-induced colitis in rats by modulating inflammation and oxidative stress. An in vivo and in silico approach. Biochem Pharmacol 2021;186:114490. [PMID: 33647259 DOI: 10.1016/j.bcp.2021.114490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 259 |
Zhou Y, He Y, Liu L, Zhou W, Wang P, Hu H, Nie Y, Chen Y. Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases. Front Nutr 2021;8:615064. [PMID: 33718417 DOI: 10.3389/fnut.2021.615064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 260 |
Dou D, Liang J, Zhai X, Li G, Wang H, Han L, Lin L, Ren Y, Liu S, Liu C, Guo W, Li J. Oxytocin signalling in dendritic cells regulates immune tolerance in the intestine and alleviates DSS-induced colitis. Clin Sci (Lond) 2021;135:597-611. [PMID: 33564880 DOI: 10.1042/CS20201438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 261 |
Lefort C, Cani PD. The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism. Cells 2021;10:400. [PMID: 33669184 DOI: 10.3390/cells10020400] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 262 |
Yang Y, Zhang C, Jing D, He H, Li X, Wang Y, Qin Y, Xiao X, Xiong H, Zhou G. IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021;27:407-17. [PMID: 32737976 DOI: 10.1093/ibd/izaa200] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 263 |
Mateus V, Estarreja J, Silva I, Barracosa P, Teixeira-lemos E, Pinto R. Effect of Cynara cardunculus L. var. altilis (DC) in Inflammatory Bowel Disease. Applied Sciences 2021;11:1629. [DOI: 10.3390/app11041629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 264 |
Chen YC, Gad SF, Chobisa D, Li Y, Yeo Y. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities. J Control Release 2021;330:438-60. [PMID: 33352244 DOI: 10.1016/j.jconrel.2020.12.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 265 |
Bauset C, Gisbert-Ferrándiz L, Cosín-Roger J. Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease. J Clin Med 2021;10:622. [PMID: 33562024 DOI: 10.3390/jcm10040622] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 266 |
Danielak A, Wojcik D, Mazur-Bialy A, Surmiak M, Bilski J, Targosz A, Magierowski M, Chmura A, Strzalka M, Krzysiek-Maczka G, Magierowska K, Szczyrk U, Kwiecien S, Ptak-Belowska A, Brzozowski T. Intestinal Alkaline Phosphatase Combined with Voluntary Physical Activity Alleviates Experimental Colitis in Obese Mice. Involvement of Oxidative Stress, Myokines, Adipokines and Proinflammatory Biomarkers. Antioxidants (Basel) 2021;10:240. [PMID: 33557311 DOI: 10.3390/antiox10020240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 267 |
Xu M, Cen M, Shen Y, Zhu Y, Cheng F, Tang L, Hu W, Dai N. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation. Dig Dis Sci 2021;66:568-76. [PMID: 32198567 DOI: 10.1007/s10620-020-06208-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 268 |
Chokr D, Cornu M, Neut C, Bortolus C, Charlet R, Desreumaux P, Speca S, Sendid B. Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine. Gut Pathog 2021;13:5. [PMID: 33509285 DOI: 10.1186/s13099-021-00401-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 269 |
Chen H, Chen L, Wang X, Ge X, Sun L, Wang Z, Xu X, Song Y, Chen J, Deng Q, Xie H, Chen T, Chen Y, Ding K, Wu J, Wang J. Transgenic overexpression of ITGB6 in intestinal epithelial cells exacerbates dextran sulfate sodium-induced colitis in mice. J Cell Mol Med 2021;25:2679-90. [PMID: 33491282 DOI: 10.1111/jcmm.16297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 270 |
Gordon M, Sinopoulou V, Akobeng AK, Lakunina S, Gjuladin-hellon T. Patient education interventions for the management of Inflammatory Bowel Disease. Cochrane Database of Systematic Reviews 2021. [DOI: 10.1002/14651858.cd013854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 271 |
Ortega Moreno L, Fernández-Tomé S, Chaparro M, Marin AC, Mora-Gutiérrez I, Santander C, Baldan-Martin M, Gisbert JP, Bernardo D. Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:268-74. [PMID: 32548643 DOI: 10.1093/ibd/izaa151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 272 |
Kang Z, Zhonga Y, Wu T, Huang J, Zhao H, Liu D. Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease. Pharmacol Rep 2021;73:700-11. [PMID: 33462754 DOI: 10.1007/s43440-020-00213-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 273 |
Zaiatz Bittencourt V, Jones F, Tosetto M, Doherty GA, Ryan EJ. Dysregulation of Metabolic Pathways in Circulating Natural Killer Cells Isolated from Inflammatory Bowel Disease Patients. J Crohns Colitis 2021;15:1316-25. [PMID: 33460436 DOI: 10.1093/ecco-jcc/jjab014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 274 |
Rempel J, Grover K, El-Matary W. Micronutrient Deficiencies and Anemia in Children with Inflammatory Bowel Disease. Nutrients 2021;13:236. [PMID: 33467587 DOI: 10.3390/nu13010236] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 275 |
Shi C, Yue F, Shi F, Qin Q, Wang L, Wang G, Mu L, Liu D, Li Y, Yu T, She J. Selenium-Containing Amino Acids Protect Dextran Sulfate Sodium-Induced Colitis via Ameliorating Oxidative Stress and Intestinal Inflammation. J Inflamm Res 2021;14:85-95. [PMID: 33488110 DOI: 10.2147/JIR.S288412] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 276 |
Shen Z, Zheng K, Zou J, Gu P, Xing J, Zhang L, Zhu L, Shen H. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial. Trials 2021;22:55. [PMID: 33441157 DOI: 10.1186/s13063-020-05012-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 277 |
Alemany-Cosme E, Sáez-González E, Moret I, Mateos B, Iborra M, Nos P, Sandoval J, Beltrán B. Oxidative Stress in the Pathogenesis of Crohn's Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics. Antioxidants (Basel) 2021;10:64. [PMID: 33430227 DOI: 10.3390/antiox10010064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 278 |
Chen F, Yang D, Wang Z. Associations Between Iron Intake and Serum Iron with Inflammatory Bowel Disease and Chronic Diarrheal Symptoms in Adults: the National Health and Nutrition Examination Survey, 2007-2010. Biol Trace Elem Res 2021. [PMID: 33409918 DOI: 10.1007/s12011-020-02550-9] [Reference Citation Analysis]
|
| 279 |
Yu Q, Zhu C, Feng S, Xu L, Hu S, Chen H, Chen H, Yao S, Wang X, Chen Y. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study. J Med Internet Res 2021;23:e20629. [PMID: 33399540 DOI: 10.2196/20629] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 280 |
Crealey M, Byrne A, Hussey S. Prevalence of IgE mediated food allergy in children with inflammatory bowel disease. Pediatr Allergy Immunol 2021;32:205-9. [PMID: 32875615 DOI: 10.1111/pai.13343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 281 |
Colman RJ, Dhaliwal J, Rosen MJ. Predicting Therapeutic Response in Pediatric Ulcerative Colitis-A Journey Towards Precision Medicine. Front Pediatr 2021;9:634739. [PMID: 33681110 DOI: 10.3389/fped.2021.634739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 282 |
Passarella A, Grewal P, Vrabie R. Diagnosis and Monitoring in Inflammatory Bowel Disease: Who, When, Where, and How. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-81780-0_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 283 |
Riffelmacher T, Giles DA, Zahner S, Dicker M, Andreyev AY, McArdle S, Perez-Jeldres T, van der Gracht E, Murray MP, Hartmann N, Tumanov AV, Kronenberg M. Metabolic activation and colitis pathogenesis is prevented by lymphotoxin β receptor expression in neutrophils. Mucosal Immunol 2021;14:679-90. [PMID: 33568785 DOI: 10.1038/s41385-021-00378-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 284 |
Zhao M, Feng R, Ben-horin S, Zhuang X, Tian Z, Zhu Y, Tang C, Li X, Ma R, Mao R, Zhang S, Lin X, Chen B, He Y, Zeng Z, Qiu Y, Chen M. A Meta-Analysis of Environmental and Dietary Risk Factors for Inflammatory Bowel Disease: A Comparison Between Eastern and Western Populations. SSRN Journal. [DOI: 10.2139/ssrn.3796865] [Reference Citation Analysis]
|
| 285 |
Beraldo RF, Baima JP, Barros JRD, Renosto FL, Saad-hossne R, Sassaki LY. The Impact of a Real-Life Inflammatory Bowel Disease Education Course for Brazilian Physicians from the Perspective of Its Participants. OJGas 2021;11:151-160. [DOI: 10.4236/ojgas.2021.119016] [Reference Citation Analysis]
|
| 286 |
Alves I, Vicente MM, Dias AM, Gaifem J, Rodrigues C, Campar A, Pinho SS. The Role of Glycosylation in Inflammatory Diseases. Adv Exp Med Biol 2021;1325:265-83. [PMID: 34495540 DOI: 10.1007/978-3-030-70115-4_13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 287 |
van Bodegraven AA, Mulder CJ, Bravenboer N. Osteoporosis associated with gastrointestinal disorders: celiac and inflammatory bowel diseases. Marcus and Feldman's Osteoporosis 2021. [DOI: 10.1016/b978-0-12-813073-5.00043-5] [Reference Citation Analysis]
|
| 288 |
Park SM, Mok JY, Cho H, Song I, Shin YJ, Lee KB, Lee BW, Bae M. Effects of Weissella confusa Wilac D001 Isolated from Dandelion Kimchi on Dextran Sulphate Sodium-Induced Colitis in Mice. Food Suppl Biomater Health 2021;1. [DOI: 10.52361/fsbh.2021.1.e25] [Reference Citation Analysis]
|
| 289 |
Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18:56-66. [PMID: 33033392 DOI: 10.1038/s41575-020-00360-x] [Cited by in Crossref: 187] [Cited by in F6Publishing: 168] [Article Influence: 93.5] [Reference Citation Analysis]
|
| 290 |
Iqbal P, Khaliq R, Sheergojri AR. Mathematical Approach in Colitis-Related Colon Cancer Genomics. Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer 2021. [DOI: 10.4018/978-1-7998-3580-6.ch008] [Reference Citation Analysis]
|
| 291 |
Lee M, Chang EB. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues. Gastroenterology 2021;160:524-37. [PMID: 33253681 DOI: 10.1053/j.gastro.2020.09.056] [Cited by in Crossref: 135] [Cited by in F6Publishing: 133] [Article Influence: 67.5] [Reference Citation Analysis]
|
| 292 |
Sultan K, Becher N. Ulcerative Colitis Diagnosis and Management: Past, Present, and Future Directions. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-81780-0_3] [Reference Citation Analysis]
|
| 293 |
Wark G, Samocha-Bonet D, Ghaly S, Danta M. The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review. Nutrients 2020;13:E135. [PMID: 33396537 DOI: 10.3390/nu13010135] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 294 |
Xie Y, Zhao Y, Shi L, Li W, Chen K, Li M, Chen X, Zhang H, Li T, Matsuzawa-Ishimoto Y, Yao X, Shao D, Ke Z, Li J, Chen Y, Zhang X, Cui J, Cui S, Leng Q, Cadwell K, Li X, Wei H, Zhang H, Li H, Xiao H. Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer. J Clin Invest 2020;130:2111-28. [PMID: 31961824 DOI: 10.1172/JCI133264] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 19.7] [Reference Citation Analysis]
|
| 295 |
Weidner J, Kern I, Manuwald U, Kugler J, Rothe U. Study protocol epidemiology of inflammatory bowel disease in childhood and adolescence: a systematic review. BMJ Open 2020;10:e037669. [PMID: 33372067 DOI: 10.1136/bmjopen-2020-037669] [Reference Citation Analysis]
|
| 296 |
Katsidzira L, Mudombi WF, Makunike-Mutasa R, Yilmaz B, Blank A, Rogler G, Macpherson A, Vavricka S, Gangaidzo I, Misselwitz B. Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case-control study. BMJ Open 2020;10:e039456. [PMID: 33371021 DOI: 10.1136/bmjopen-2020-039456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 297 |
Peng S, Shen L, Tian MX, Li HM, Wang SS. Poly(ADP-ribose) polymerase-1 inhibitor ameliorates dextran sulfate sodium-induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting the NF-κB signaling pathway. Exp Ther Med 2021;21:134. [PMID: 33376516 DOI: 10.3892/etm.2020.9566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 298 |
Liu H, Li T, Zhong S, Yu M, Huang W. Intestinal epithelial cells related lncRNA and mRNA expression profiles in dextran sulphate sodium-induced colitis. J Cell Mol Med 2021;25:1060-73. [PMID: 33300279 DOI: 10.1111/jcmm.16174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 299 |
Ng SC, Mak JWY, Pal P, Banerjee R. Optimising management strategies of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol Hepatol 2020;5:1089-100. [PMID: 33181088 DOI: 10.1016/S2468-1253(20)30298-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 300 |
Stakenborg M, Verstockt B, Meroni E, Goverse G, De Simone V, Verstockt S, Di Matteo M, Czarnewski P, Villablanca EJ, Ferrante M, Boeckxstaens GE, Mazzone M, Vermeire S, Matteoli G. Neutrophilic HGF-MET Signalling Exacerbates Intestinal Inflammation. J Crohns Colitis 2020;14:1748-58. [PMID: 32556102 DOI: 10.1093/ecco-jcc/jjaa121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 301 |
Hsieh M, Hsu W, Wang J, Wang Y, Hu H, Chang W, Chen C, Wu D, Kuo F, Su W. Nutritional and dietary strategy in the clinical care of inflammatory bowel disease. Journal of the Formosan Medical Association 2020;119:1742-9. [DOI: 10.1016/j.jfma.2019.09.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 302 |
Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:643-54. [PMID: 33121686 DOI: 10.1016/j.gtc.2020.07.005] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 28.7] [Reference Citation Analysis]
|
| 303 |
Kong L, Lloyd-Price J, Vatanen T, Seksik P, Beaugerie L, Simon T, Vlamakis H, Sokol H, Xavier RJ. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease. Gastroenterology 2020;159:2193-2202.e5. [PMID: 32860788 DOI: 10.1053/j.gastro.2020.08.045] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 304 |
Goodman WA, Erkkila IP, Pizarro TT. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:740-54. [PMID: 32901108 DOI: 10.1038/s41575-020-0354-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 305 |
Juliao Baños F, Torres Amaya. M, Otero Regino W, Vallejo MT, Galiano MT, Feliciano J, Máquez JR, Concha Mejía A, Gil Parada F. Guía para el manejo de colitis ulcerativa en población adulta (actualización). Rev Colomb Gastroenterol 2020;35:2-62. [DOI: 10.22516/25007440.636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 306 |
Kotze PG, DamiÃo AOMC. Research in inflammatory bowel disease in Brazil: a step forward towards patient care. Arq Gastroenterol 2020;57:225-6. [PMID: 33206810 DOI: 10.1590/S0004-2803.202000000-43] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 307 |
Lv H, Jin M, Zhang H, Chen X, Wu M, Guo M, Zhou R, Wang Z, Yang H, Qian J. Increasing newly diagnosed inflammatory bowel disease and improving prognosis in China: a 30-year retrospective study from a single centre. BMC Gastroenterol 2020;20:377. [PMID: 33183228 DOI: 10.1186/s12876-020-01527-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 308 |
Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158854. [PMID: 33157277 DOI: 10.1016/j.bbalip.2020.158854] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 309 |
Chong Y, Han C, Li J, Long X. Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019. J Int Med Res 2020;48:300060520965824. [PMID: 33115290 DOI: 10.1177/0300060520965824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 310 |
Sun Y, Li L, Lai A, Xiao W, Wang K, Wang L, Niu J, Luo J, Chen H, Dai L, Miao Y. Does Ulcerative Colitis Influence the Inter-individual Heterogeneity of the Human Intestinal Mucosal Microbiome? Evol Bioinform Online 2020;16:1176934320948848. [PMID: 33100827 DOI: 10.1177/1176934320948848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 311 |
Zhuang X, Tian Z, Feng R, Li M, Li T, Zhou G, Qiu Y, Chen B, He Y, Chen M, Zeng Z, Zhang S. Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn's Disease. Inflamm Bowel Dis 2020;26:1636-47. [PMID: 33026078 DOI: 10.1093/ibd/izaa253] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 312 |
Hu JE, Bojarski C, Branchi F, Fromm M, Krug SM. Leptin Downregulates Angulin-1 in Active Crohn's Disease via STAT3. Int J Mol Sci 2020;21:E7824. [PMID: 33105684 DOI: 10.3390/ijms21217824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 313 |
Cheng F, Li Q, Wang J, Zeng F, Wang K, Zhang Y. Identification of Differential Intestinal Mucosa Transcriptomic Biomarkers for Ulcerative Colitis by Bioinformatics Analysis. Dis Markers 2020;2020:8876565. [PMID: 33144895 DOI: 10.1155/2020/8876565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 314 |
Naeem M, Lee J, Oshi MA, Cao J, Hlaing SP, Im E, Jung Y, Yoo JW. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis. Acta Biomater 2020;116:368-82. [PMID: 32937207 DOI: 10.1016/j.actbio.2020.09.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 315 |
Altajar S, Moss A. Inflammatory Bowel Disease Environmental Risk Factors: Diet and Gut Microbiota. Curr Gastroenterol Rep 2020;22:57. [PMID: 33044636 DOI: 10.1007/s11894-020-00794-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 316 |
Silvestri C, Pagano E, Lacroix S, Venneri T, Cristiano C, Calignano A, Parisi OA, Izzo AA, Di Marzo V, Borrelli F. Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis. Front Pharmacol 2020;11:585096. [PMID: 33162890 DOI: 10.3389/fphar.2020.585096] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 317 |
Zong S, Ye Z, Zhang X, Chen H, Ye M. Protective effect of Lachnum polysaccharide on dextran sulfate sodium-induced colitis in mice. Food Funct 2020;11:846-59. [PMID: 31934694 DOI: 10.1039/c9fo02719j] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 318 |
Lee HS, Lee J, Smolensky D, Lee SH. Potential benefits of patchouli alcohol in prevention of human diseases: A mechanistic review. Int Immunopharmacol 2020;89:107056. [PMID: 33039955 DOI: 10.1016/j.intimp.2020.107056] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 319 |
Zhang T, Kayani MUR, Hong L, Zhang C, Zhong J, Wang Z, Chen L. Dynamics of the Salivary Microbiome During Different Phases of Crohn's Disease. Front Cell Infect Microbiol 2020;10:544704. [PMID: 33123492 DOI: 10.3389/fcimb.2020.544704] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 320 |
Rozich JJ, Dulai PS, Fumery M, Sandborn WJ, Singh S. Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies. Clin Gastroenterol Hepatol 2020;18:2437-2447.e6. [PMID: 32142940 DOI: 10.1016/j.cgh.2020.02.048] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 321 |
Eshelman MA, Harris L, Deiling S, Koltun WA, Jeganathan NA, Yochum GS. Transcriptomic analysis of ileal tissue from Crohn's disease patients identifies extracellular matrix genes that distinguish individuals by age at diagnosis. Physiol Genomics 2020;52:478-84. [PMID: 32866088 DOI: 10.1152/physiolgenomics.00062.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 322 |
Kaibullayeva J, Ualiyeva A, Oshibayeva A, Dushpanova A, Marshall JK. Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study. Intest Res 2020;18:430-7. [PMID: 32988164 DOI: 10.5217/ir.2019.00099] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 323 |
Saedi AA, Sharma S, Hassan EB, Chen L, Ghasem-zadeh A, Hassanzadeganroudsari M, Gooi JH, Stavely R, Eri R, Miao D, Nurgali K, Duque G. Skeletal Phenotype and Mechanisms of Bone Loss in Winnie Mice as a Model for Inflammatory Bowel Disease.. [DOI: 10.1101/2020.09.28.317495] [Reference Citation Analysis]
|
| 324 |
Wang L, An J, Song S, Mei M, Li W, Ding F, Liu S. Electroacupuncture preserves intestinal barrier integrity through modulating the gut microbiota in DSS-induced chronic colitis. Life Sci 2020;261:118473. [PMID: 32971101 DOI: 10.1016/j.lfs.2020.118473] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 325 |
Ewid M, Al Mutiri N, Al Omar K, Shamsan AN, Rathore AA, Saquib N, Salaas A, Al Sarraj O, Nasri Y, Attal A, Tawfiq A, Sherif H. Updated bone mineral density status in Saudi patients with inflammatory bowel disease. World J Gastroenterol 2020; 26(35): 5343-5353 [PMID: 32994692 DOI: 10.3748/wjg.v26.i35.5343] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 326 |
Zhang L, Shao F, Li L. Association of Copper and Zinc Intake with Inflammatory Bowel Disease and Fecal Incontinence Symptoms: Evidence from the National Health and Nutrition Examination Survey. Biol Trace Elem Res 2021;199:2543-51. [PMID: 32939644 DOI: 10.1007/s12011-020-02390-7] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 327 |
Zhao B, Xia B, Li X, Zhang L, Liu X, Shi R, Kou R, Liu Z, Liu X. Sesamol Supplementation Attenuates DSS-Induced Colitis via Mediating Gut Barrier Integrity, Inflammatory Responses, and Reshaping Gut Microbiome. J Agric Food Chem 2020;68:10697-708. [PMID: 32893621 DOI: 10.1021/acs.jafc.0c04370] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 328 |
Xu W, Ding W, Gu Y, Cui L, Zhong J, Du P. Risk Factors of Colorectal Stricture Associated with Developing High-Grade Dysplasia or Cancer in Ulcerative Colitis: A Multicenter Long-term Follow-up Study. Gut Liver 2020;14:601-10. [PMID: 31816674 DOI: 10.5009/gnl19229] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 329 |
Xu W, Ding W, Gu Y, Cui L, Zhong J, Du P. Risk Factors of Colorectal Stricture Associated with Developing High-Grade Dysplasia or Cancer in Ulcerative Colitis: A Multicenter Long-term Follow-up Study. Gut Liver 2020;14:601-10. [PMID: 31816674 DOI: 10.5009/gnl19229] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 330 |
Hu J, Huang H, Che Y, Ding C, Zhang L, Wang Y, Hao H, Shen H, Cao L. Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function. J Ethnopharmacol 2021;266:113394. [PMID: 32941971 DOI: 10.1016/j.jep.2020.113394] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 331 |
Shah SC, Itzkowitz SH. Reappraising Risk Factors for Inflammatory Bowel Disease-associated Neoplasia: Implications for Colonoscopic Surveillance in IBD. J Crohns Colitis 2020;14:1172-7. [PMID: 32150256 DOI: 10.1093/ecco-jcc/jjaa040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 332 |
Zhong M, Sun Y, Wang HG, Marcella C, Cui BT, Miao YL, Zhang FM. Awareness and attitude of fecal microbiota transplantation through transendoscopic enteral tubing among inflammatory bowel disease patients. World J Clin Cases 2020; 8(17): 3786-3796 [PMID: 32953854 DOI: 10.12998/wjcc.v8.i17.3786] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 333 |
Rodríguez-Lago I, Zabana Y, Barreiro-de Acosta M. Diagnosis and natural history of preclinical and early inflammatory bowel disease. Ann Gastroenterol 2020;33:443-52. [PMID: 32879589 DOI: 10.20524/aog.2020.0508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 334 |
Chiba M, Tsuji T, Komatsu M, Watanabe H, Takahashi M. Ulcerative colitis in the postpartum period. Autops Case Rep 2020;10:e2020187. [PMID: 33344315 DOI: 10.4322/acr.2020.187] [Reference Citation Analysis]
|
| 335 |
Park S, Kang Y, Koh H, Kim S. Increasing incidence of inflammatory bowel disease in children and adolescents: significance of environmental factors. Clin Exp Pediatr 2020;63:337-44. [PMID: 32024322 DOI: 10.3345/cep.2019.00500] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 336 |
Liang H, Luo Z, Miao Z, Shen X, Li M, Zhang X, Chen J, Ze X, Chen Q, He F. Lactobacilli and bifidobacteria derived from infant intestines may activate macrophages and lead to different IL-10 secretion. Biosci Biotechnol Biochem 2020;84:2558-68. [PMID: 32862788 DOI: 10.1080/09168451.2020.1811948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 337 |
Wang Q, Li XL, Mei Y, Ye JC, Fan W, Cheng GH, Zeng MS, Feng GK. The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer. J Mol Med (Berl) 2020;98:1457-66. [PMID: 32840638 DOI: 10.1007/s00109-020-01963-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 338 |
Cohen BL, Gallinger ZR, Ha C, Holubar SD, Hou JK, Kinnucan J, Mahadevan U, Moss AC, Raffals LE, Regueiro M, Szigethy E, Wolf D, Dubinsky MC, Patel A, Shah BJ, Ehrlich OG, Hanauer SB. Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States. Inflamm Bowel Dis 2020;26:1291-305. [PMID: 32820340 DOI: 10.1093/ibd/izaa177] [Reference Citation Analysis]
|
| 339 |
Shimodaira Y, Onochi K, Watanabe K, Takahashi S, Fukuda S, Watanabe N, Koizumi S, Matsuhashi T, Iijima K. Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan. Intest Res 2021;19:225-31. [PMID: 32806877 DOI: 10.5217/ir.2020.00023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 340 |
Nguyen LH, Örtqvist AK, Cao Y, Simon TG, Roelstraete B, Song M, Joshi AD, Staller K, Chan AT, Khalili H, Olén O, Ludvigsson JF. Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. Lancet Gastroenterol Hepatol 2020;5:986-95. [PMID: 32818437 DOI: 10.1016/S2468-1253(20)30267-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 63] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 341 |
Ayelén R, Pablo A, Sofía Q, Jimena C, Renata S, Carolina C, Claudia M, Iraola G, Federico CL, Alberto P, Belforte Fiorella S. New insights in Ulcerative Colitis Associated Gut Microbiota in South American Population: Akkermansia and Collinsella, two distinctive genera found in Argentine subjects.. [DOI: 10.1101/2020.07.29.20164764] [Reference Citation Analysis]
|
| 342 |
Epstein D, Kassianides C, Gaibee Z, Watermeyer G, Griffiths A. Inflammatory bowel disease in children in sub-Saharan Africa. Paediatr Int Child Health 2020;40:141-2. [PMID: 32772905 DOI: 10.1080/20469047.2020.1787020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 343 |
Emile SH, Gilshtein H, Wexner SD. Outcome of Ileal Pouch-anal Anastomosis in Patients With Indeterminate Colitis: A Systematic Review and Meta-analysis. J Crohns Colitis 2020;14:1010-20. [PMID: 31912129 DOI: 10.1093/ecco-jcc/jjaa002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 344 |
de Jong ME, Smits LJT, van Ruijven B, den Broeder N, Russel MGVM, Römkens TEH, West RL, Jansen JM, Hoentjen F. Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients. J Crohns Colitis 2020;14:888-95. [PMID: 31974546 DOI: 10.1093/ecco-jcc/jjaa012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 345 |
Yan X, Qiao Y, Tong J, Mao R, Liang J, Lv C, Chen Y, Wang Y, Shen J; Young Investigators for the study of Inflammatory Bowel Diseases (YIIBD). Assessment of patient-centered outcomes (PROs) in inflammatory bowel disease (IBD): a multicenter survey preceding a cross-disciplinary (functional) consensus. Health Qual Life Outcomes 2020;18:241. [PMID: 32690091 DOI: 10.1186/s12955-020-01489-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 346 |
Zou Q, Zhang X, Liu X, Li Y, Tan Q, Dan Q, Yuan T, Liu X, Liu RH, Liu Z. Ficus carica polysaccharide attenuates DSS-induced ulcerative colitis in C57BL/6 mice. Food Funct 2020;11:6666-79. [PMID: 32658237 DOI: 10.1039/d0fo01162b] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 347 |
Salgado VCL, Luiz RR, Boéchat NLF, Leão IS, Schorr BDC, Parente JML, Lima DC, Silveira Júnior ES, Silva GOS, Almeida NP, Vieira A, de Bueno MLQ, Chebli JM, Bertges ÉR, Brugnara LMDC, Junqueira Neto C, Campbell SBG, Discacciati LL, Cézar JPS, Nunes T, Kaplan GG, Zaltman C. Risk factors associated with inflammatory bowel disease: A multicenter case-control study in Brazil. World J Gastroenterol 2020; 26(25): 3611-3624 [PMID: 32742130 DOI: 10.3748/wjg.v26.i25.3611] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 348 |
Reinisch W, Gecse K, Halfvarson J, Irving PM, Jahnsen J, Peyrin-Biroulet L, Rogler G, Schreiber S, Danese S. Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease. Inflamm Bowel Dis 2021;27:106-22. [PMID: 32634212 DOI: 10.1093/ibd/izaa078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 349 |
AlRuthia Y, Almadi M, Aljebreen A, Azzam N, Alsharif W, Alrasheed H, Almuaythir G, Saeed M, HajkhderMullaissa B, Alharbi O. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia. J Med Econ 2020;23:1102-10. [PMID: 32619388 DOI: 10.1080/13696998.2020.1791889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 350 |
Payros D, Ménard S, Laffitte J, Neves M, Tremblay-Franco M, Luo S, Fouche E, Snini SP, Theodorou V, Pinton P, Oswald IP. The food contaminant, deoxynivalenol, modulates the Thelper/Treg balance and increases inflammatory bowel diseases. Arch Toxicol 2020;94:3173-84. [PMID: 32617661 DOI: 10.1007/s00204-020-02817-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 351 |
Seo JW, Kim ES, Han MH, Kweon YO. Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn's disease. Intest Res 2021;19:247-51. [PMID: 32610890 DOI: 10.5217/ir.2020.00016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 352 |
Bajaj JS, Brenner DM, Cai Q, Cash BD, Crowell M, DiBaise J, Gallegos-Orozco JF, Gardner TB, Gyawali CP, Ha C, Holtmann G, Jamil LH, Kaplan GG, Karsan HA, Kinoshita Y, Lebwohl B, Leontiadis GI, Lichtenstein GR, Longstreth GF, Muthusamy VR, Oxentenko AS, Pimentel M, Pisegna JR, Rubenstein JH, Russo MW, Saini SD, Samadder NJ, Shaukat A, Simren M, Stevens T, Valdovinos M, Vargas H, Spiegel B, Lacy BE. Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. Am J Gastroenterol 2020;115:1007-18. [PMID: 32618649 DOI: 10.14309/ajg.0000000000000709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 353 |
Li T, Qiu Y, Yang HS, Li MY, Zhuang XJ, Zhang SH, Feng R, Chen BL, He Y, Zeng ZR, Chen MH. Systematic review and meta-analysis: Association of a pre-illness Western dietary pattern with the risk of developing inflammatory bowel disease. J Dig Dis 2020;21:362-71. [PMID: 32463159 DOI: 10.1111/1751-2980.12910] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 354 |
Pickert G, Wirtz S, Matzner J, Ashfaq-Khan M, Heck R, Rosigkeit S, Thies D, Surabattula R, Ehmann D, Wehkamp J, Aslam M, He G, Weigert A, Foerster F, Klotz L, Frick JS, Becker C, Bockamp E, Schuppan D. Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis. Gastroenterology 2020;159:257-272.e17. [PMID: 32251667 DOI: 10.1053/j.gastro.2020.03.064] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 355 |
Huang YW, Echeveste CE, Oshima K, Zhang J, Yearsley M, Yu J, Wang LS. Anti-colonic Inflammation by Black Raspberries through Regulating Toll-like Receptor-4 Signaling in Interlukin-10 Knockout Mice. J Cancer Prev 2020;25:119-25. [PMID: 32647653 DOI: 10.15430/JCP.2020.25.2.119] [Reference Citation Analysis]
|
| 356 |
Nebbia M, Yassin NA, Spinelli A. Colorectal Cancer in Inflammatory Bowel Disease. Clin Colon Rectal Surg 2020;33:305-17. [PMID: 32968366 DOI: 10.1055/s-0040-1713748] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 357 |
Day AS. Re: Parental Education May Differentially Modulate Pediatric Inflammatory Bowel Disease Phenotype Risk. Inflamm Bowel Dis 2020;26:1077-8. [PMID: 31587055 DOI: 10.1093/ibd/izz235] [Reference Citation Analysis]
|
| 358 |
Rangan P, Choi I, Wei M, Navarrete G, Guen E, Brandhorst S, Enyati N, Pasia G, Maesincee D, Ocon V, Abdulridha M, Longo VD. Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology. Cell Rep 2019;26:2704-2719.e6. [PMID: 30840892 DOI: 10.1016/j.celrep.2019.02.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 124] [Article Influence: 38.3] [Reference Citation Analysis]
|
| 359 |
Rozich JJ, Holmer A, Singh S. Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases. Am J Gastroenterol 2020;115:832-40. [PMID: 32224703 DOI: 10.14309/ajg.0000000000000608] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 360 |
Gregory MH, Ciorba MA, Wiitala WL, Stidham RW, Higgins P, Morley SC, Hou JK, Feagins LA, Govani SM, Cohen-Mekelburg SA, Waljee AK. The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:919-25. [PMID: 31504531 DOI: 10.1093/ibd/izz189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 361 |
Kim H, Jeong Y, Kang S, You HJ, Ji GE. Co-Culture with Bifidobacterium catenulatum Improves the Growth, Gut Colonization, and Butyrate Production of Faecalibacterium prausnitzii: In Vitro and In Vivo Studies. Microorganisms 2020;8:E788. [PMID: 32466189 DOI: 10.3390/microorganisms8050788] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 362 |
Yu Q, Zhu C, Feng S, Xu L, Hu S, Chen H, Chen H, Yao S, Wang X, Chen Y. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study (Preprint).. [DOI: 10.2196/preprints.20629] [Reference Citation Analysis]
|
| 363 |
Verdugo-Meza A, Ye J, Dadlani H, Ghosh S, Gibson DL. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients 2020;12:E1434. [PMID: 32429195 DOI: 10.3390/nu12051434] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 364 |
Chen X, Li M, Li D, Luo T, Xie Y, Gao L, Zhang Y, Chen S, Li S, Huang G, Li W, Su J, Lai X. Ethanol extract of Pycnoporus sanguineus relieves the dextran sulfate sodium-induced experimental colitis by suppressing helper T cell-mediated inflammation via apoptosis induction. Biomed Pharmacother 2020;127:110212. [PMID: 32422567 DOI: 10.1016/j.biopha.2020.110212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 365 |
Colquhoun C, Duncan M, Grant G. Inflammatory Bowel Diseases: Host-Microbial-Environmental Interactions in Dysbiosis. Diseases 2020;8:E13. [PMID: 32397606 DOI: 10.3390/diseases8020013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 366 |
Peter I, Maldonado-Contreras A, Eisele C, Frisard C, Simpson S, Nair N, Rendon A, Hawkins K, Cawley C, Debebe A, Tarassishin L, White S, Dubinsky M, Stone J, Clemente JC, Sabino J, Torres J, Hu J, Colombel JF, Olendzki B. A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: The MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial design. Contemp Clin Trials Commun 2020;18:100573. [PMID: 32617430 DOI: 10.1016/j.conctc.2020.100573] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 367 |
Thi Thanh Tran H, Saito S, Noto S, Suzuki K. Quality of Life and Eligibility for Specific Financial Assistance for Medical Expenses: A Cross-Sectional Web-Based Survey among Patients with Inflammatory Bowel Disease in Japan. GastrointestDisord 2020;2:123-33. [DOI: 10.3390/gidisord2020012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 368 |
Ananthakrishnan AN, Kaplan GG, Ng SC. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century. Clin Gastroenterol Hepatol 2020;18:1252-60. [PMID: 32007542 DOI: 10.1016/j.cgh.2020.01.028] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 31.0] [Reference Citation Analysis]
|
| 369 |
Bewtra M, Lichtenstein GR. Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD: When Trial Design Is as Important as Disease Therapy. Am J Gastroenterol 2020;115:687-8. [PMID: 32195732 DOI: 10.14309/ajg.0000000000000564] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 370 |
Kopiasz Ł, Dziendzikowska K, Gajewska M, Wilczak J, Harasym J, Żyła E, Kamola D, Oczkowski M, Królikowski T, Gromadzka-Ostrowska J. Time-Dependent Indirect Antioxidative Effects of Oat Beta-Glucans on Peripheral Blood Parameters in the Animal Model of Colon Inflammation. Antioxidants (Basel) 2020;9:E375. [PMID: 32365955 DOI: 10.3390/antiox9050375] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 371 |
Wei M, Gao X, Liu L, Li Z, Wan Z, Dong Y, Chen X, Niu Y, Zhang J, Yang G. Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity via Pro-inflammatory MiRNAs in High Fat Diet Fed Mice. ACS Nano 2020;14:5099-110. [PMID: 32275391 DOI: 10.1021/acsnano.0c01860] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 372 |
Porter RJ, Kalla R, Ho GT. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Res 2020;9:F1000 Faculty Rev-294. [PMID: 32399194 DOI: 10.12688/f1000research.20805.1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 373 |
Chen P, Zhou G, Lin J, Li L, Zeng Z, Chen M, Zhang S. Serum Biomarkers for Inflammatory Bowel Disease. Front Med (Lausanne). 2020;7:123. [PMID: 32391365 DOI: 10.3389/fmed.2020.00123] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 374 |
Sarbagili-shabat C, Zelber-sagi S, Fliss Isakov N, Ron Y, Hirsch A, Maharshak N. Development and validation of processed foods questionnaire (PFQ) in adult inflammatory bowel diseases patients. Eur J Clin Nutr 2020;74:1653-60. [DOI: 10.1038/s41430-020-0632-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 375 |
Lee P, Chiou Y, Nagabhushanam K, Ho C, Pan M. 3′-Hydroxypterostilbene Potently Alleviates Obesity Exacerbated Colitis in Mice. J Agric Food Chem 2020;68:5365-74. [DOI: 10.1021/acs.jafc.0c01782] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 376 |
Chandrasekaran A, Molparia B, Akhtar E, Wang X, Lewis JD, Chang JT, Oliveira G, Torkamani A, Konijeti GG. The Autoimmune Protocol Diet Modifies Intestinal RNA Expression in Inflammatory Bowel Disease. Crohns Colitis 360 2019;1:otz016. [PMID: 32309803 DOI: 10.1093/crocol/otz016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 377 |
Liu YJ, Tang B, Wang FC, Tang L, Lei YY, Luo Y, Huang SJ, Yang M, Wu LY, Wang W, Liu S, Yang SM, Zhao XY. Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner. Theranostics 2020;10:5225-41. [PMID: 32373209 DOI: 10.7150/thno.43716] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 378 |
Nguyen LH, Ma W, Wang DD, Cao Y, Mallick H, Gerbaba TK, Lloyd-Price J, Abu-Ali G, Hall AB, Sikavi D, Drew DA, Mehta RS, Arze C, Joshi AD, Yan Y, Branck T, DuLong C, Ivey KL, Ogino S, Rimm EB, Song M, Garrett WS, Izard J, Huttenhower C, Chan AT. Association Between Sulfur-Metabolizing Bacterial Communities in Stool and Risk of Distal Colorectal Cancer in Men. Gastroenterology 2020;158:1313-25. [PMID: 31972239 DOI: 10.1053/j.gastro.2019.12.029] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 20.7] [Reference Citation Analysis]
|
| 379 |
Hu B, Yu S, Shi C, Gu J, Shao Y, Chen Q, Li Y, Mezzenga R. Amyloid-Polyphenol Hybrid Nanofilaments Mitigate Colitis and Regulate Gut Microbial Dysbiosis. ACS Nano 2020;14:2760-76. [PMID: 31961657 DOI: 10.1021/acsnano.9b09125] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 380 |
Caër C, Wick MJ. Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease. Front Immunol 2020;11:410. [PMID: 32256490 DOI: 10.3389/fimmu.2020.00410] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 381 |
Xiao M, Shen Z, Luo W, Tan B, Meng X, Wu X, Wu S, Nie K, Tong T, Hong J, Wang X, Wang X. A new colitis therapy strategy via the target colonization of magnetic nanoparticle-internalized Roseburia intestinalis. Biomater Sci 2019;7:4174-85. [PMID: 31380882 DOI: 10.1039/c9bm00980a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 382 |
Piovani D, Danese S, Peyrin-Biroulet L, Bonovas S. Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study. J Crohns Colitis 2020;14:323-31. [PMID: 31504350 DOI: 10.1093/ecco-jcc/jjz150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 383 |
Ye Y, Manne S, Treem WR, Bennett D. Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016. Inflamm Bowel Dis 2020;26:619-25. [PMID: 31504515 DOI: 10.1093/ibd/izz182] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 384 |
Bikbavova GR, Livzan MA, Zastavnaya AA. Virom of intestinal canal and ulcerative colitis: new facets of interaction. jour 2020;1:66-71. [DOI: 10.31146/1682-8658-ecg-170-10-66-71] [Reference Citation Analysis]
|
| 385 |
Komaki S, Haque A, Miyazaki H, Matsumoto T, Nakamura S. Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice. J Infect Chemother 2020;26:549-53. [PMID: 32122783 DOI: 10.1016/j.jiac.2020.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 386 |
Chiba M, Nakane K, Tsuji T, Tsuda S, Ishii H, Ohno H, Watanabe K, Obara Y, Komatsu M, Sugawara T. Relapse Prevention by Plant-Based Diet Incorporated into Induction Therapy for Ulcerative Colitis: A Single-Group Trial. Perm J 2019;23. [PMID: 31050638 DOI: 10.7812/TPP/18-220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 387 |
Zhou G, Chen L, Sun Q, Mo QG, Sun WC, Wang YW. Maqui berry exhibited therapeutic effects against DSS-induced ulcerative colitis in C57BL/6 mice. Food Funct 2019;10:6655-65. [PMID: 31556890 DOI: 10.1039/c9fo00663j] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 388 |
Chaubey P, Momin M, Sawarkar S. Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders. Front Pharmacol 2019;10:1628. [PMID: 32161536 DOI: 10.3389/fphar.2019.01628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 389 |
Zhao M, Bendtsen F, Petersen AM, Larsen L, Dige A, Hvas C, Seidelin JB, Burisch J. Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy-the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study. BMJ Open 2020;10:e035756. [PMID: 32102828 DOI: 10.1136/bmjopen-2019-035756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 390 |
Serrant L. Silenced Knowing: An Intersectional Framework for Exploring Black Women's Health and Diasporic Identities. Front Sociol 2020;5:1. [PMID: 33869410 DOI: 10.3389/fsoc.2020.00001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 391 |
Zhang R, Yuan S, Ye J, Wang X, Zhang X, Shen J, Yuan M, Liao W. Polysaccharide from flammuliana velutipes improves colitis via regulation of colonic microbial dysbiosis and inflammatory responses. Int J Biol Macromol 2020;149:1252-61. [PMID: 32035958 DOI: 10.1016/j.ijbiomac.2020.02.044] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 392 |
Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature 2020;578:527-39. [PMID: 32103191 DOI: 10.1038/s41586-020-2025-2] [Cited by in Crossref: 264] [Cited by in F6Publishing: 263] [Article Influence: 88.0] [Reference Citation Analysis]
|
| 393 |
Soh H, Im JP, Han K, Park S, Hong SW, Moon JM, Kang EA, Chun J, Lee HJ, Kim JS. Crohn's disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population-based study. Aliment Pharmacol Ther 2020;51:446-56. [PMID: 31691306 DOI: 10.1111/apt.15562] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 394 |
Kotze PG, Underwood FE, Damião AOMC, Ferraz JGP, Saad-Hossne R, Toro M, Iade B, Bosques-Padilla F, Teixeira FV, Juliao-Banos F, Simian D, Ghosh S, Panaccione R, Ng SC, Kaplan GG. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review. Clin Gastroenterol Hepatol 2020;18:304-12. [PMID: 31252191 DOI: 10.1016/j.cgh.2019.06.030] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 26.3] [Reference Citation Analysis]
|
| 395 |
Ciapponi A, Virgilio SA, Berrueta M, Soto NC, Ciganda Á, Rojas Illanes MF, Rubio Martinez B, Gamba J, González Salazar CA, Rocha Rodríguez JN, Scarpellini B, Bravo Perdomo AM, Machnicki G, Aldunate L, De Paula J, Bardach A. Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study. PLoS One 2020;15:e0228256. [PMID: 31986191 DOI: 10.1371/journal.pone.0228256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 396 |
Moon JM, Kang EA, Han K, Hong SW, Soh H, Park S, Lee J, Lee HJ, Im JP, Kim JS. Trends and risk factors of elderly-onset Crohn’s disease: A nationwide cohort study. World J Gastroenterol 2020; 26(4): 404-415 [PMID: 32063689 DOI: 10.3748/wjg.v26.i4.404] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 397 |
Lu X, Xie S, Ye L, Zhu L, Yu Q. Lactobacillus Protects Against S. Typhimurium-Induced Intestinal Inflammation by Determining the Fate of Epithelial Proliferation and Differentiation. Mol Nutr Food Res 2020;64:e1900655. [PMID: 31953989 DOI: 10.1002/mnfr.201900655] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 398 |
Fu H, Kaminga AC, Peng Y, Feng T, Wang T, Wu X, Yang T. Associations between disease activity, social support and health-related quality of life in patients with inflammatory bowel diseases: the mediating role of psychological symptoms. BMC Gastroenterol 2020;20:11. [PMID: 31937264 DOI: 10.1186/s12876-020-1166-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 399 |
Chen JF, Luo DD, Lin YS, Liu YH, Wu JZ, Yi XQ, Wu Y, Zhang Q, Gao CJ, Cai J, Su ZR. Aqueous extract of Bruguiera gymnorrhiza leaves protects against dextran sulfate sodium induced ulcerative colitis in mice via suppressing NF-κB activation and modulating intestinal microbiota. J Ethnopharmacol 2020;251:112554. [PMID: 31923541 DOI: 10.1016/j.jep.2020.112554] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 400 |
Dong LN, Wang M, Guo J, Wang JP. Role of intestinal microbiota and metabolites in inflammatory bowel disease. Chin Med J (Engl) 2019;132:1610-4. [PMID: 31090547 DOI: 10.1097/CM9.0000000000000290] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 401 |
Hartmann F. CED im höheren Lebensalter. Chronisch-entzündliche Darmerkrankungen 2020. [DOI: 10.1007/978-3-662-59104-8_31] [Reference Citation Analysis]
|
| 402 |
Winter MW, Weinstock JV. Inflammatory Bowel Disease. The Autoimmune Diseases 2020. [DOI: 10.1016/b978-0-12-812102-3.00046-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 403 |
Wang Z, Chen T, Yang C, Bao T, Yang X, He F, Zhang Y, Zhu L, Chen H, Rong S, Yang S. Secoisolariciresinol diglucoside suppresses Dextran sulfate sodium salt-induced colitis through inhibiting NLRP1 inflammasome. International Immunopharmacology 2020;78:105931. [DOI: 10.1016/j.intimp.2019.105931] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 404 |
Piovani D, Danese S, Peyrin-Biroulet L, Bonovas S. Inflammatory bowel disease: estimates from the global burden of disease 2017 study. Aliment Pharmacol Ther 2020;51:261-70. [PMID: 31660629 DOI: 10.1111/apt.15542] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 405 |
Parigi TL, Roda G, Argollo M, Gilardi D, Danese S. Is there a role for therapeutic sphingolipids in inflammatory bowel disease? Expert Rev Gastroenterol Hepatol 2020;14:47-54. [PMID: 31874053 DOI: 10.1080/17474124.2020.1709446] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 406 |
Kee BP, Ng JG, Ng CC, Hilmi I, Goh KL, Chua KH. Genetic polymorphisms of ATG16L1 and IRGM genes in Malaysian patients with Crohn's disease. J Dig Dis 2020;21:29-37. [PMID: 31654602 DOI: 10.1111/1751-2980.12829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 407 |
Mamun AA, Hossain MS, Khallil ME, Tahabilder A, Das TK, Islam R. Convenient Way to Detect Ulcer in Wireless Capsule Endoscopy Through Fuzzy Logic Technique. 2020 IEEE Region 10 Symposium (TENSYMP) 2020. [DOI: 10.1109/tensymp50017.2020.9231004] [Reference Citation Analysis]
|
| 408 |
Newberry C, Parks EP, Maqbool A. Nutrition and gastrointestinal disorders. Present Knowledge in Nutrition 2020. [DOI: 10.1016/b978-0-12-818460-8.00023-x] [Reference Citation Analysis]
|
| 409 |
Wang Y, Zhang H, He H, Ai K, Yu W, Xiao X, Qin Y, Zhang L, Xiong H, Zhou G. LRCH1 suppresses migration of CD4(+) T cells and refers to disease activity in ulcerative colitis. Int J Med Sci 2020;17:599-608. [PMID: 32210709 DOI: 10.7150/ijms.39106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 410 |
Kang B, Kim JE, Jung JH, Choe JY, Kim MJ, Choe YH, Kim S, Koh H, Lee YM, Lee JH, Lee Y, Lee JH, Lee HJ, Jang HJ, Choi Y, Choi SY, Kim JY, Choe BH. Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts. Pediatr Gastroenterol Hepatol Nutr 2020;23:49-62. [PMID: 31988875 DOI: 10.5223/pghn.2020.23.1.49] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 411 |
Keller K. Medikamentöse Therapie der CED bei Kindern und Jugendlichen. Chronisch-entzündliche Darmerkrankungen 2020. [DOI: 10.1007/978-3-662-59104-8_28] [Reference Citation Analysis]
|
| 412 |
Hossain MS, Al Mamun A, Ghosh T, Hasan MG, Hossain MM, Tahabilder A. Ulcer Detection in Wireless Capsule Endoscopy Using Locally Computed Features. Cyber Security and Computer Science 2020. [DOI: 10.1007/978-3-030-52856-0_39] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 413 |
Kim S, Park S, Kang Y, Koh H. Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis. Eur J Gastroenterol Hepatol 2020;32:17-21. [PMID: 31651657 DOI: 10.1097/MEG.0000000000001550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 414 |
Nyman M, Nguyen TD, Wikman O, Hjortswang H, Hallert C. Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis-Randomized Controlled Trial. Crohns Colitis 360 2020;2:otaa005. [PMID: 36777965 DOI: 10.1093/crocol/otaa005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 415 |
Balbas-martinez V, Asin-prieto E, Parra-guillen ZP, Troconiz IF. A Quantitative Systems Pharmacology Model for the Key Interleukins Involved in Crohn's Disease. J Pharmacol Exp Ther 2020;372:299-307. [DOI: 10.1124/jpet.119.260539] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 416 |
Godny L, Reshef L, Pfeffer-Gik T, Goren I, Yanai H, Tulchinsky H, Gophna U, Dotan I. Adherence to the Mediterranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery. Eur J Nutr 2020;59:3183-90. [PMID: 31813010 DOI: 10.1007/s00394-019-02158-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 417 |
D'Haens GRAM, Lindsay JO, Panaccione R, Schreiber S. Ulcerative Colitis: Shifting Sands. Drugs R D 2019;19:227-34. [PMID: 30827006 DOI: 10.1007/s40268-019-0263-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 418 |
Rapa SF, Waltenberger B, Di Paola R, Adesso S, Siracusa R, Peritore AF, D'Amico R, Autore G, Cuzzocrea S, Stuppner H, Marzocco S. Plumericin prevents intestinal inflammation and oxidative stress in vitro and in vivo. FASEB J 2020;34:1576-90. [PMID: 31914614 DOI: 10.1096/fj.201902040R] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 419 |
Kucharzik T. Colitis ulcerosa leitliniengerecht behandeln. Gastroenterologe 2019;14:415-422. [DOI: 10.1007/s11377-019-00387-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 420 |
Lam S, Zuo T, Ho M, Chan FKL, Chan PKS, Ng SC. Review article: fungal alterations in inflammatory bowel diseases. Aliment Pharmacol Ther 2019;50:1159-71. [PMID: 31648369 DOI: 10.1111/apt.15523] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 421 |
Fan Y, Yi W, Huang H, Mei Z, Feng Z. Efficacy of herbal medicine (Gegen Qinlian Decoction) on ulcerative colitis: A systematic review of randomized controlled trials. Medicine (Baltimore) 2019;98:e18512. [PMID: 31876740 DOI: 10.1097/MD.0000000000018512] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 422 |
Pigneur B, Ruemmele FM. Nutritional interventions for the treatment of IBD: current evidence and controversies. Therap Adv Gastroenterol 2019;12:1756284819890534. [PMID: 31803252 DOI: 10.1177/1756284819890534] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 423 |
Safarpour AR, Mehrabi M, Keshtkar A, Edjtehadi F, Bagheri Lankarani K. Systematic review and meta-analysis of the incidence and prevalence and 30-year trend of inflammatory bowel diseases in Asia: a study protocol. BMJ Open 2019;9:e031854. [PMID: 31748306 DOI: 10.1136/bmjopen-2019-031854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 424 |
He Y, Li X, Yu H, Ge Y, Liu Y, Qin X, Jiang M, Wang X. The Functional Role of Fecal Microbiota Transplantation on Dextran Sulfate Sodium-Induced Colitis in Mice. Front Cell Infect Microbiol 2019;9:393. [PMID: 31803633 DOI: 10.3389/fcimb.2019.00393] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 425 |
Byron C, Cornally N, Burton A, Savage E. Challenges of living with and managing inflammatory bowel disease: A meta-synthesis of patients' experiences. J Clin Nurs 2020;29:305-19. [PMID: 31631440 DOI: 10.1111/jocn.15080] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 426 |
Bąk-Romaniszyn L, Świerzko AS, Sokołowska A, Durko Ł, Mierzwa G, Szala-Poździej A, Małecka-Panas E, Cedzyński M. Mannose-binding lectin (MBL) in adult patients with inflammatory bowel disease. Immunobiology 2020;225:151859. [PMID: 31703823 DOI: 10.1016/j.imbio.2019.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 427 |
Thoo L, Noti M, Krebs P. Keep calm: the intestinal barrier at the interface of peace and war. Cell Death Dis 2019;10:849. [PMID: 31699962 DOI: 10.1038/s41419-019-2086-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 14.8] [Reference Citation Analysis]
|
| 428 |
Xu W, Guo Y, Huang Z, Zhao H, Zhou M, Huang Y, Wen D, Song J, Zhu Z, Sun M, Liu CY, Chen Y, Cui L, Wang X, Liu Z, Yang Y, Du P. Small heat shock protein CRYAB inhibits intestinal mucosal inflammatory responses and protects barrier integrity through suppressing IKKβ activity. Mucosal Immunol 2019;12:1291-303. [PMID: 31481750 DOI: 10.1038/s41385-019-0198-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 429 |
Pagano E, Romano B, Iannotti F, Parisi O, D’armiento M, Pignatiello S, Coretti L, Lucafò M, Venneri T, Stocco G, Lembo F, Orlando P, Capasso R, Di Marzo V, Izzo A, Borrelli F. The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients. Pharmacological Research 2019;149:104464. [DOI: 10.1016/j.phrs.2019.104464] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 430 |
Guo J, Li D, Tao H, Li G, Liu R, Dou Y, Jin T, Li L, Huang J, Hu H, Zhang J. Cyclodextrin-Derived Intrinsically Bioactive Nanoparticles for Treatment of Acute and Chronic Inflammatory Diseases. Adv Mater 2019;31:e1904607. [PMID: 31583783 DOI: 10.1002/adma.201904607] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 431 |
Zeng Z, Mukherjee A, Zhang H. From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease. Front Genet. 2019;10:1017. [PMID: 31737035 DOI: 10.3389/fgene.2019.01017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 432 |
Sifuentes-Dominguez LF, Li H, Llano E, Liu Z, Singla A, Patel AS, Kathania M, Khoury A, Norris N, Rios JJ, Starokadomskyy P, Park JY, Gopal P, Liu Q, Tan S, Chan L, Ross T, Harrison S, Venuprasad K, Baker LA, Jia D, Burstein E. SCGN deficiency results in colitis susceptibility. Elife 2019;8:e49910. [PMID: 31663849 DOI: 10.7554/eLife.49910] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 433 |
Metzger CE, Narayanan SA, Elizondo JP, Carter AM, Zawieja DC, Hogan HA, Bloomfield SA. DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone. Sci Rep 2019;9:15144. [PMID: 31641205 DOI: 10.1038/s41598-019-51550-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 434 |
Nunes R, Neves JD, Sarmento B. Nanoparticles for the regulation of intestinal inflammation: opportunities and challenges. Nanomedicine (Lond) 2019;14:2631-44. [PMID: 31612773 DOI: 10.2217/nnm-2019-0191] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 435 |
Choi YI, Kim TJ, Park DK, Chung JW, Kim KO, Kwon KA, Kim YJ. Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease. Int J Colorectal Dis 2019;34:1713-21. [PMID: 31471699 DOI: 10.1007/s00384-019-03368-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 436 |
Kim S. Tacrolimus in pediatric ulcerative colitis: does it have a role? Intest Res 2019;17:441-2. [PMID: 31665831 DOI: 10.5217/ir.2019.00124] [Reference Citation Analysis]
|
| 437 |
Drescher H, Lissoos T, Hajisafari E, Evans ER. Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers. The Journal for Nurse Practitioners 2019;15:676-81. [DOI: 10.1016/j.nurpra.2019.07.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 438 |
Andersen MJ, Yvellez OV, El Jurdi K, Sossenheimer PH, Lei D, Pearl TA, Zmeter N, Rubin DT. Simplification of Validated Patient-Reported Outcome Instruments in Inflammatory Bowel Disease. Crohn's & Colitis 360 2019;1. [DOI: 10.1093/crocol/otz043] [Reference Citation Analysis]
|
| 439 |
Chandrasekaran A, Groven S, Lewis JD, Levy SS, Diamant C, Singh E, Konijeti GG. An Autoimmune Protocol Diet Improves Patient-Reported Quality of Life in Inflammatory Bowel Disease. Crohns Colitis 360 2019;1:otz019. [PMID: 31832627 DOI: 10.1093/crocol/otz019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 440 |
Carman N, Mack DR, Benchimol EI. Anticipatory care of children and adolescents with inflammatory bowel disease: a primer for primary care providers. Curr Opin Pediatr 2019;31:654-60. [PMID: 31205126 DOI: 10.1097/MOP.0000000000000795] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 441 |
Godny L, Maharshak N, Reshef L, Goren I, Yahav L, Fliss-Isakov N, Gophna U, Tulchinsky H, Dotan I. Fruit Consumption is Associated with Alterations in Microbial Composition and Lower Rates of Pouchitis. J Crohns Colitis 2019;13:1265-72. [PMID: 30828722 DOI: 10.1093/ecco-jcc/jjz053] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 442 |
Ciccocioppo R, Fioravante M, Frulloni L. Mesenchymal stromal cell therapy in intestinal diseases. Curr Opin Organ Transplant 2018;23:679-89. [PMID: 30300331 DOI: 10.1097/MOT.0000000000000586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 443 |
Thomas T, Chandan JS, Li VSW, Lai CY, Tang W, Bhala N, Kaplan GG, Ng SC, Ghosh S. Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts. PLoS One 2019;14:e0221961. [PMID: 31545811 DOI: 10.1371/journal.pone.0221961] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 444 |
Eichele DD, Young R. Medical Management of Inflammatory Bowel Disease. Surg Clin North Am 2019;99:1223-35. [PMID: 31676060 DOI: 10.1016/j.suc.2019.08.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 445 |
Ni Y, Liu M, Yu H, Chen Y, Liu Y, Chen S, Ruan J, Da A, Zhang Y, Wang T. Desmethylbellidifolin From Gentianella acuta Ameliorate TNBS-Induced Ulcerative Colitis Through Antispasmodic Effect and Anti-Inflammation. Front Pharmacol 2019;10:1104. [PMID: 31616306 DOI: 10.3389/fphar.2019.01104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 446 |
Li C, Zhao Y, Cheng J, Guo J, Zhang Q, Zhang X, Ren J, Wang F, Huang J, Hu H, Wang R, Zhang J. A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota. Adv Sci (Weinh) 2019;6:1900610. [PMID: 31559126 DOI: 10.1002/advs.201900610] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 20.3] [Reference Citation Analysis]
|
| 447 |
Picardo S, Kaplan GG, Sharkey KA, Seow CH. Insights into the role of cannabis in the management of inflammatory bowel disease. Therap Adv Gastroenterol 2019;12:1756284819870977. [PMID: 31523278 DOI: 10.1177/1756284819870977] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 448 |
Frolkis AD, Vallerand IA, Shaheen AA, Lowerison MW, Swain MG, Barnabe C, Patten SB, Kaplan GG. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Gut 2019;68:1606-12. [PMID: 30337374 DOI: 10.1136/gutjnl-2018-317182] [Cited by in Crossref: 110] [Cited by in F6Publishing: 109] [Article Influence: 27.5] [Reference Citation Analysis]
|
| 449 |
Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses. Gastroenterology 2019;157:647-659.e4. [PMID: 31014995 DOI: 10.1053/j.gastro.2019.04.016] [Cited by in Crossref: 265] [Cited by in F6Publishing: 265] [Article Influence: 66.3] [Reference Citation Analysis]
|
| 450 |
Prasad SS, Potter M, Keely S, Talley NJ, Walker MM, Kairuz T. Roles of healthcare professionals in the management of chronic gastrointestinal diseases with a focus on primary care: A systematic review. JGH Open 2020;4:221-9. [PMID: 32280768 DOI: 10.1002/jgh3.12235] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 451 |
Szilagyi A. Relationship(s) between obesity and inflammatory bowel diseases: possible intertwined pathogenic mechanisms. Clin J Gastroenterol 2020;13:139-52. [PMID: 31452062 DOI: 10.1007/s12328-019-01037-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 452 |
Laffin M, Fedorak R, Zalasky A, Park H, Gill A, Agrawal A, Keshteli A, Hotte N, Madsen KL. A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice. Sci Rep. 2019;9:12294. [PMID: 31444382 DOI: 10.1038/s41598-019-48749-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 453 |
Li X, Wang Q, Ding L, Wang YX, Zhao ZD, Mao N, Wu CT, Wang H, Zhu H, Ning SB. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens. Stem Cell Res Ther 2019;10:267. [PMID: 31443680 DOI: 10.1186/s13287-019-1384-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 454 |
Xia X, Zhu L, Lei Z, Song Y, Tang F, Yin Z, Wang J, Huang J. Feruloylated Oligosaccharides Alleviate Dextran Sulfate Sodium-Induced Colitis in Vivo. J Agric Food Chem 2019;67:9522-31. [DOI: 10.1021/acs.jafc.9b03647] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 455 |
Trivedi I, Darguzas E, Balbale SN, Bedell A, Reddy S, Rosh JR, Keefer L. Patient Understanding of "Flare" and "Remission" of Inflammatory Bowel Disease. Gastroenterol Nurs 2019;42:375-85. [PMID: 31365426 DOI: 10.1097/SGA.0000000000000373] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 456 |
Burgos-edwards A, Martín-pérez L, Jiménez-aspee F, Theoduloz C, Schmeda-hirschmann G, Larrosa M. Anti-inflammatory effect of polyphenols from Chilean currants (Ribes magellanicum and R. punctatum) after in vitro gastrointestinal digestion on Caco-2 cells. Journal of Functional Foods 2019;59:329-36. [DOI: 10.1016/j.jff.2019.06.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 457 |
Barnig C, Bezema T, Calder PC, Charloux A, Frossard N, Garssen J, Haworth O, Dilevskaya K, Levi-Schaffer F, Lonsdorfer E, Wauben M, Kraneveld AD, Te Velde AA. Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease. Front Immunol 2019;10:1699. [PMID: 31396220 DOI: 10.3389/fimmu.2019.01699] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 458 |
Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep. 2019;21:40. [PMID: 31338613 DOI: 10.1007/s11894-019-0705-6] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 459 |
Andoh A, Inoue R, Kawada Y, Morishima S, Inatomi O, Ohno M, Bamba S, Nishida A, Kawahara M, Naito Y. Elemental diet induces alterations of the gut microbial community in mice. J Clin Biochem Nutr 2019;65:118-24. [PMID: 31592206 DOI: 10.3164/jcbn.19-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 460 |
Gou S, Huang Y, Sung J, Xiao B, Merlin D. Silk fibroin-based nanotherapeutics: application in the treatment of colonic diseases. Nanomedicine (Lond) 2019;14:2373-8. [PMID: 31290366 DOI: 10.2217/nnm-2019-0058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 461 |
Schreiner P, Neurath MF, Ng SC, El-Omar EM, Sharara AI, Kobayashi T, Hisamatsu T, Hibi T, Rogler G. Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More. Inflamm Intest Dis 2019;4:79-96. [PMID: 31559260 DOI: 10.1159/000500721] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 462 |
Quaresma AB, Kaplan GG, Kotze PG. The globalization of inflammatory bowel disease: the incidence and prevalence of inflammatory bowel disease in Brazil. Curr Opin Gastroenterol 2019;35:259-64. [PMID: 30973356 DOI: 10.1097/MOG.0000000000000534] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 463 |
Fritsch J, Abreu MT. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg? Gastrointest Endosc Clin N Am 2019;29:381-93. [PMID: 31078242 DOI: 10.1016/j.giec.2019.02.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 464 |
Ha JE, Jang EJ, Im SG, Sohn HS. Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014). Korean J Clin Pharm 2019;29:79-88. [DOI: 10.24304/kjcp.2019.29.2.79] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 465 |
Genkel VV, Portnova RG, Antipina TV, Shaposhnik II. Regional Arterial Stiffness in Patients with Inflammatory Bowel Disease. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2019;29:66-73. [DOI: 10.22416/1382-4376-2019-29-3-66-73] [Reference Citation Analysis]
|
| 466 |
Xu W, Ou W, Guo Y, Gu Y, Cui L, Zhong J, Du P. Clinical outcomes and risk factors of secondary extraintestinal manifestation in ulcerative colitis: results of a multicenter and long-term follow-up retrospective study. PeerJ 2019;7:e7194. [PMID: 31304061 DOI: 10.7717/peerj.7194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 467 |
Song G, Fiocchi C, Achkar JP. Acupuncture in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1129-39. [PMID: 30535303 DOI: 10.1093/ibd/izy371] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 468 |
Chiba M, Nakane K, Komatsu M. Westernized Diet is the Most Ubiquitous Environmental Factor in Inflammatory Bowel Disease. Perm J. 2019;23:18-107. [PMID: 30624192 DOI: 10.7812/tpp/18-107] [Cited by in Crossref: 34] [Cited by in F6Publishing: 42] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 469 |
Hwang YJ, Nam SJ, Chun W, Kim SI, Park SC, Kang CD, Lee SJ. Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis model. PLoS One 2019;14:e0217642. [PMID: 31141554 DOI: 10.1371/journal.pone.0217642] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 470 |
López-Pérez AE, Nurgali K, Abalo R. Painful neurotrophins and their role in visceral pain. Behav Pharmacol 2018;29:120-39. [PMID: 29543647 DOI: 10.1097/FBP.0000000000000386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 471 |
Marion-Letellier R, Amamou A, Savoye G, Ghosh S. Inflammatory Bowel Diseases and Food Additives: To Add Fuel on the Flames! Nutrients 2019;11:E1111. [PMID: 31109097 DOI: 10.3390/nu11051111] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 472 |
Cheng C, Hua J, Tan J, Qian W, Zhang L, Hou X. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis. Exp Ther Med 2019;18:278-88. [PMID: 31258663 DOI: 10.3892/etm.2019.7541] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 473 |
Mamun AA, Hossain MS, Hossain MM, Hasan MG. Discretion Way for Bleeding Detection in Wireless Capsule Endoscopy Images. 2019 1st International Conference on Advances in Science, Engineering and Robotics Technology (ICASERT) 2019. [DOI: 10.1109/icasert.2019.8934589] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 474 |
Schwerd T, Koletzko S. Darmmikrobiom und chronisch-entzündliche Darmerkrankungen. Monatsschr Kinderheilkd 2019;167:420-425. [DOI: 10.1007/s00112-019-0683-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 475 |
Singh S, Stitt LW, Zou G, Khanna R, Dulai PS, Sandborn WJ, Feagan BG, Jairath V. Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT. Aliment Pharmacol Ther 2019;49:1188-94. [PMID: 30891808 DOI: 10.1111/apt.15214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 476 |
Zhang YW, Xu XY, Zhang J, Yao X, Lu C, Chen CX, Yu CH, Sun J. Missense mutation in PRKCQ is associated with Crohn's disease. J Dig Dis 2019;20:243-7. [PMID: 30828974 DOI: 10.1111/1751-2980.12717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 477 |
Mamun AA, Hossain MS. Ulcer Detection in Image Converted from Video Footage of Wireless Capsule Endoscopy. 2019 1st International Conference on Advances in Science, Engineering and Robotics Technology (ICASERT) 2019. [DOI: 10.1109/icasert.2019.8934597] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 478 |
Olivera P, Danese S, Jay N, Natoli G, Peyrin-Biroulet L. Big data in IBD: a look into the future. Nat Rev Gastroenterol Hepatol 2019;16:312-21. [PMID: 30659247 DOI: 10.1038/s41575-019-0102-5] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 479 |
Teigen LM, Geng Z, Sadowsky MJ, Vaughn BP, Hamilton MJ, Khoruts A. Dietary Factors in Sulfur Metabolism and Pathogenesis of Ulcerative Colitis. Nutrients 2019;11:E931. [PMID: 31027194 DOI: 10.3390/nu11040931] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 480 |
Scarozza P, Schmitt H, Monteleone G, Neurath MF, Atreya R. Oligonucleotides-A Novel Promising Therapeutic Option for IBD. Front Pharmacol 2019;10:314. [PMID: 31068803 DOI: 10.3389/fphar.2019.00314] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 481 |
Zheng JD, He Y, Yu HY, Liu YL, Ge YX, Li XT, Li X, Wang Y, Guo MR, Qu YL, Qin XF, Jiang MS, Wang XH. Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation. World J Gastroenterol 2019; 25(15): 1865-1878 [PMID: 31057300 DOI: 10.3748/wjg.v25.i15.1865] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 482 |
Youssif C, Cubillos-Rojas M, Comalada M, Llonch E, Perna C, Djouder N, Nebreda AR. Myeloid p38α signaling promotes intestinal IGF-1 production and inflammation-associated tumorigenesis. EMBO Mol Med 2018;10:e8403. [PMID: 29907597 DOI: 10.15252/emmm.201708403] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 483 |
He Y, Yu H, Ge Y, Li X, Jiang M, Liu Y, Li X, Wang Y, Guo M, Qin X, Wang X. Bacterial β-glucuronidase alleviates dextran sulfate sodium-induced colitis in mice: A possible crucial new diagnostic and therapeutic target for inflammatory bowel disease. Biochem Biophys Res Commun 2019;513:426-33. [PMID: 30967260 DOI: 10.1016/j.bbrc.2019.03.196] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 484 |
Takagi T, Homma T, Fujii J, Shirasawa N, Yoriki H, Hotta Y, Higashimura Y, Mizushima K, Hirai Y, Katada K, Uchiyama K, Naito Y, Itoh Y. Elevated ER stress exacerbates dextran sulfate sodium-induced colitis in PRDX4-knockout mice. Free Radical Biology and Medicine 2019;134:153-64. [DOI: 10.1016/j.freeradbiomed.2018.12.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 485 |
Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology 2019;156:1508-24. [PMID: 30658060 DOI: 10.1053/j.gastro.2018.12.022] [Cited by in Crossref: 162] [Cited by in F6Publishing: 160] [Article Influence: 40.5] [Reference Citation Analysis]
|
| 486 |
Weaver KN, Long MD. Preventive Medicine in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2019;17:824-8. [PMID: 30529728 DOI: 10.1016/j.cgh.2018.11.054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 487 |
Riestra S, Castaño-garcía A, Pérez-martínez RDFEI. Enfermedad inflamatoria intestinal: aspectos prácticos para el médico de familia. FMC - Formación Médica Continuada en Atención Primaria 2019;26:195-204. [DOI: 10.1016/j.fmc.2018.06.010] [Reference Citation Analysis]
|
| 488 |
Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Am J Obstet Gynecol 2019;220:308-23. [PMID: 30948039 DOI: 10.1016/j.ajog.2019.02.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 489 |
King JA, Underwood FE, Panaccione N, Quan J, Windsor JW, Kotze PG, Ng SC, Ghosh S, Lakatos PL, Jess T, Panaccione R, Seow CH, Ben-horin S, Burisch J, Colombel J, Loftus EV, Gearry R, Halfvarson J, Kaplan GG. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development. The Lancet Gastroenterology & Hepatology 2019;4:287-95. [DOI: 10.1016/s2468-1253(19)30013-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 490 |
Lorén V, Garcia-Jaraquemada A, Naves JE, Carmona X, Mañosa M, Aransay AM, Lavin JL, Sánchez I, Cabré E, Manyé J, Domènech E. ANP32E, a Protein Involved in Steroid-Refractoriness in Ulcerative Colitis, Identified by a Systems Biology Approach. J Crohns Colitis 2019;13:351-61. [PMID: 30329026 DOI: 10.1093/ecco-jcc/jjy171] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 491 |
Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Inflamm Bowel Dis 2019;25:627-41. [PMID: 30821832 DOI: 10.1093/ibd/izz037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 492 |
Duan B, Li M, Sun Y, Zou S, Xu X. Orally Delivered Antisense Oligodeoxyribonucleotides of TNF-α via Polysaccharide-Based Nanocomposites Targeting Intestinal Inflammation. Adv Healthc Mater 2019;8:e1801389. [PMID: 30714345 DOI: 10.1002/adhm.201801389] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 493 |
Body-Malapel M, Djouina M, Waxin C, Langlois A, Gower-Rousseau C, Zerbib P, Schmidt AM, Desreumaux P, Boulanger E, Vignal C. The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases. Mucosal Immunol 2019;12:468-78. [PMID: 30542111 DOI: 10.1038/s41385-018-0119-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 494 |
Meng X, Dunsmore G, Koleva P, Elloumi Y, Wu RY, Sutton RT, Ambrosio L, Hotte N, Nguyen V, Madsen KL, Dieleman LA, Chen H, Huang V, Elahi S. The Profile of Human Milk Metabolome, Cytokines, and Antibodies in Inflammatory Bowel Diseases Versus Healthy Mothers, and Potential Impact on the Newborn. J Crohns Colitis 2019;13:431-41. [PMID: 30418545 DOI: 10.1093/ecco-jcc/jjy186] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 495 |
Matthews SM, Eshelman MA, Berg AS, Koltun WA, Yochum GS. The Crohn's disease associated SNP rs6651252 impacts MYC gene expression in human colonic epithelial cells. PLoS One 2019;14:e0212850. [PMID: 30794691 DOI: 10.1371/journal.pone.0212850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 496 |
Fan H, Gao Z, Ji K, Li X, Wu J, Liu Y, Wang X, Liang H, Liu Y, Li X, Liu P, Chen D, Zhao F. The in vitro and in vivo anti-inflammatory effect of osthole, the major natural coumarin from Cnidium monnieri (L.) Cuss, via the blocking of the activation of the NF-κB and MAPK/p38 pathways. Phytomedicine 2019;58:152864. [PMID: 30878874 DOI: 10.1016/j.phymed.2019.152864] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 497 |
Imai T, Inoue R, Kawada Y, Morita Y, Inatomi O, Nishida A, Bamba S, Kawahara M, Andoh A. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease. J Gastroenterol 2019;54:149-59. [PMID: 30478724 DOI: 10.1007/s00535-018-1530-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 498 |
Ozawa T, Ishihara S, Fujishiro M, Saito H, Kumagai Y, Shichijo S, Aoyama K, Tada T. Novel computer-assisted diagnosis system for endoscopic disease activity in patients with ulcerative colitis. Gastrointest Endosc 2019;89:416-421.e1. [PMID: 30367878 DOI: 10.1016/j.gie.2018.10.020] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 499 |
Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Jahnsen J, Ricanek P, Vatn S, Moen AEF, Tannæs TM, Lindstrøm JC, Söderholm JD, Halfvarson J, Gomollón F, Casén C, Karlsson MK, Kalla R, Adams AT, Satsangi J, Perminow G. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome. Clin Exp Gastroenterol 2019;12:37-49. [PMID: 30774408 DOI: 10.2147/CEG.S186235] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 500 |
Simian D, Quera R. Inflammatory Bowel Disease in Latin America: A Systematic Review. Value Health Reg Issues 2019;20:19-20. [PMID: 30622033 DOI: 10.1016/j.vhri.2018.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 501 |
Haberman Y, Karns R, Dexheimer PJ, Schirmer M, Somekh J, Jurickova I, Braun T, Novak E, Bauman L, Collins MH, Mo A, Rosen MJ, Bonkowski E, Gotman N, Marquis A, Nistel M, Rufo PA, Baker SS, Sauer CG, Markowitz J, Pfefferkorn MD, Rosh JR, Boyle BM, Mack DR, Baldassano RN, Shah S, Leleiko NS, Heyman MB, Grifiths AM, Patel AS, Noe JD, Aronow BJ, Kugathasan S, Walters TD, Gibson G, Thomas SD, Mollen K, Shen-Orr S, Huttenhower C, Xavier RJ, Hyams JS, Denson LA. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat Commun 2019;10:38. [PMID: 30604764 DOI: 10.1038/s41467-018-07841-3] [Cited by in Crossref: 133] [Cited by in F6Publishing: 134] [Article Influence: 33.3] [Reference Citation Analysis]
|
| 502 |
Weimers P, Ankersen DV, Munkholm P. Biomarkers for Remote Monitoring. Biomarkers in Inflammatory Bowel Diseases 2019. [DOI: 10.1007/978-3-030-11446-6_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 503 |
de Boer NKH; Thiopurine Working Group. Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones. Gastroenterology 2019;156:11-4. [PMID: 30472233 DOI: 10.1053/j.gastro.2018.11.039] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 504 |
Zhang L, Wu T. Inflammatory Bowel Disease. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases 2019. [DOI: 10.1007/978-3-030-15573-5_15] [Reference Citation Analysis]
|
| 505 |
Ng SC, Kaplan GG, Tang W, Banerjee R, Adigopula B, Underwood FE, Tanyingoh D, Wei SC, Lin WC, Lin HH, Li J, Bell S, Niewiadomski O, Kamm MA, Zeng Z, Chen M, Hu P, Ong D, Ooi CJ, Ling KL, Miao Y, Miao J, Janaka de Silva H, Niriella M, Aniwan S, Limsrivilai J, Pisespongsa P, Wu K, Yang H, Ng KK, Yu HH, Wang Y, Ouyang Q, Abdullah M, Simadibrata M, Gunawan J, Hilmi I, Lee Goh K, Cao Q, Sheng H, Ong-Go A, Chong VH, Ching JYL, Wu JCY, Chan FKL, Sung JJY. Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific. Am J Gastroenterol 2019;114:107-15. [PMID: 30177785 DOI: 10.1038/s41395-018-0233-2] [Cited by in Crossref: 111] [Cited by in F6Publishing: 115] [Article Influence: 27.8] [Reference Citation Analysis]
|
| 506 |
Hjortswang H. Management of de Novo Crohn’s Disease after Reconstructive Surgery with Continent Ileostomy in Ulcerative Colitis. The Kock Pouch 2019. [DOI: 10.1007/978-3-319-95591-9_15] [Reference Citation Analysis]
|
| 507 |
Xu M, Duan X, Chen Q, Fan H, Hong Z, Deng S, Nan Z, Wu H, Dong Y, Liu Y, Zhou C. Effect of compound sophorae decoction on dextran sodium sulfate (DSS)-induced colitis in mice by regulating Th17/Treg cell balance. Biomedicine & Pharmacotherapy 2019;109:2396-408. [DOI: 10.1016/j.biopha.2018.11.087] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 508 |
Quera R, Simian D, Pizarro G, Lubascher J, Kronberg U, Ibáñez P, Flores L, Figueroa C. Desarrollo de investigación y academia a partir de la labor clínica: Experiencia de un Programa de Enfermedad Inflamatoria Intestinal. Revista Médica Clínica Las Condes 2019;30:70-75. [DOI: 10.1016/j.rmclc.2018.12.001] [Reference Citation Analysis]
|
| 509 |
Goren I, Barkan R, Dotan I. Pouch Care. Inflammatory Bowel Disease Nursing Manual 2019. [DOI: 10.1007/978-3-319-75022-4_31] [Reference Citation Analysis]
|
| 510 |
Sun Y, Li L, Xie R, Wang B, Jiang K, Cao H. Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults. Front Pediatr 2019;7:432. [PMID: 31709203 DOI: 10.3389/fped.2019.00432] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 511 |
Kumagai J, Taida T, Ogasawara S, Nakagawa T, Iino Y, Shingyoji A, Ishikawa K, Akizue N, Yamato M, Takahashi K, Ohta Y, Hamanaka S, Okimoto K, Nakamura M, Ohyama H, Saito K, Kusakabe Y, Maruoka D, Yasui S, Matsumura T, Sugiyama H, Sakai Y, Mikata R, Arai M, Katsuno T, Tsuyuguchi T, Kato N. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients. PLoS One. 2018;13:e0209352. [PMID: 30571774 DOI: 10.1371/journal.pone.0209352] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 512 |
Tatiya-aphiradee N, Chatuphonprasert W, Jarukamjorn K. Immune response and inflammatory pathway of ulcerative colitis. Journal of Basic and Clinical Physiology and Pharmacology 2018;30:1-10. [DOI: 10.1515/jbcpp-2018-0036] [Cited by in Crossref: 107] [Cited by in F6Publishing: 113] [Article Influence: 21.4] [Reference Citation Analysis]
|
| 513 |
Reed S. The Emerging Treatment Landscape of Inflammatory Bowel Disease: Role of Innovator Biologics and Biosimilars. EMJ Gastroenterol 2018. [DOI: 10.33590/emjgastroenterol/10314260] [Reference Citation Analysis]
|
| 514 |
Parkes M, Noor NM, Dowling F, Leung H, Bond S, Whitehead L, Upponi S, Kinnon P, Sandham AP, Lyons PA, McKinney EF, Smith KGC, Lee JC. PRedicting Outcomes For Crohn's dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial. BMJ Open 2018;8:e026767. [PMID: 30523133 DOI: 10.1136/bmjopen-2018-026767] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 515 |
Dotti I, Salas A. Potential Use of Human Stem Cell-Derived Intestinal Organoids to Study Inflammatory Bowel Diseases. Inflamm Bowel Dis 2018;24:2501-9. [PMID: 30169820 DOI: 10.1093/ibd/izy275] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
|
| 516 |
Wang K, Zhang Z, Liu K, Yang X, Zou H, Zhou J, Miao X, Chen W, Xiong L, Wen Y. Neat1-miRNA204-5p-PI3K-AKT axis as a potential mechanism for photodynamic therapy treated colitis in mice. Photodiagnosis and Photodynamic Therapy 2018;24:349-57. [DOI: 10.1016/j.pdpdt.2018.10.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 517 |
Takagi T, Naito Y, Mizushima K, Hirai Y, Harusato A, Okayama T, Katada K, Kamada K, Uchiyama K, Handa O, Ishikawa T, Itoh Y. Heme oxygenase-1 prevents murine intestinal inflammation. J Clin Biochem Nutr 2018;63:169-74. [PMID: 30487665 DOI: 10.3164/jcbn.17-133] [Reference Citation Analysis]
|
| 518 |
Yen HH, Weng MT, Tung CC, Wang YT, Chang YT, Chang CH, Shieh MJ, Wong JM, Wei SC. Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study. Intest Res 2019;17:54-62. [PMID: 30449079 DOI: 10.5217/ir.2018.00096] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 15.2] [Reference Citation Analysis]
|
| 519 |
Park S, Chun J, Han KD, Soh H, Choi K, Kim JH, Lee J, Lee C, Im JP, Kim JS. Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol 2018; 24(42): 4798-4808 [PMID: 30479466 DOI: 10.3748/wjg.v24.i42.4798] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 520 |
Xie R, Sun Y, Wu J, Huang S, Jin G, Guo Z, Zhang Y, Liu T, Liu X, Cao X, Wang B, Cao H. Maternal High Fat Diet Alters Gut Microbiota of Offspring and Exacerbates DSS-Induced Colitis in Adulthood. Front Immunol 2018;9:2608. [PMID: 30483266 DOI: 10.3389/fimmu.2018.02608] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 521 |
Benchimol EI, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Siddiq S, Windsor JW, Carroll MW, Coward S, El-Matary W, Griffiths AM, Jones JL, Kuenzig ME, Lee L, Mack DR, Mawani M, Otley AR, Singh H, Targownik LE, Weizman AV, Kaplan GG. The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada. J Can Assoc Gastroenterol 2019;2:S1-5. [PMID: 31294380 DOI: 10.1093/jcag/gwy052] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 522 |
Kaplan GG, Bernstein CN, Coward S, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology. J Can Assoc Gastroenterol 2019;2:S6-S16. [PMID: 31294381 DOI: 10.1093/jcag/gwy054] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 523 |
Soularue E, Lepage P, Colombel JF, Coutzac C, Faleck D, Marthey L, Collins M, Chaput N, Robert C, Carbonnel F. Enterocolitis due to immune checkpoint inhibitors: a systematic review. Gut 2018;67:2056-67. [PMID: 30131322 DOI: 10.1136/gutjnl-2018-316948] [Cited by in Crossref: 127] [Cited by in F6Publishing: 130] [Article Influence: 25.4] [Reference Citation Analysis]
|
| 524 |
Brunet E, Roig-Ramos C, Vela E, Clèries M, Melcarne L, Villòria A, Pontes C, Calvet X. Prevalence, incidence and mortality of inflammatory bowel disease in Catalonia. A population-based analysis. Ann Med 2018;50:613-9. [PMID: 30247071 DOI: 10.1080/07853890.2018.1523550] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 525 |
Ruiz MA, Kaiser Junior RL, Piron-Ruiz L, Peña-Arciniegas T, Saran PS, De Quadros LG. Hematopoietic stem cell transplantation for Crohn's disease: Gaps, doubts and perspectives. World J Stem Cells 2018;10:134-7. [PMID: 30397423 DOI: 10.4252/wjsc.v10.i10.134] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 526 |
Zhang H, Zeng Z, Mukherjee A, Shen B. Molecular diagnosis and classification of inflammatory bowel disease. Expert Rev Mol Diagn. 2018;18:867-886. [PMID: 30152711 DOI: 10.1080/14737159.2018.1516549] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 527 |
Fernando EH, Gordon MH, Beck PL, Macnaughton WK. Inhibition of Intestinal Epithelial Wound Healing through Protease-Activated Receptor-2 Activation in Caco2 Cells. J Pharmacol Exp Ther 2018;367:382-92. [DOI: 10.1124/jpet.118.249524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 528 |
Sharara AI, Al Awadhi S, Alharbi O, Al Dhahab H, Mounir M, Salese L, Singh E, Sunna N, Tarcha N, Mosli M. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East. Expert Rev Gastroenterol Hepatol 2018;12:883-97. [PMID: 30096985 DOI: 10.1080/17474124.2018.1503052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 529 |
Aljomah G, Baker SS, Schmidt K, Alkhouri R, Kozielski R, Zhu L, Baker RD. Anemia in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;67:351-5. [PMID: 29668567 DOI: 10.1097/MPG.0000000000002002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 530 |
Begun J. Predictors in inflammatory bowel disease: Looking into the magic ball: Session one summary. J Gastroenterol Hepatol 2018;33 Suppl 3:4. [PMID: 30187557 DOI: 10.1111/jgh.14415] [Reference Citation Analysis]
|
| 531 |
Ko Y. Inflammatory bowel disease environmental risk factors versus genetics based on migration epidemiological studies. J Gastroenterol Hepatol 2018;33 Suppl 3:22. [PMID: 30187554 DOI: 10.1111/jgh.14427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 532 |
de Meij TGJ, de Groot EFJ, Peeters CFW, de Boer NKH, Kneepkens CMF, Eck A, Benninga MA, Savelkoul PHM, van Bodegraven AA, Budding AE. Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. PLoS One 2018;13:e0197649. [PMID: 30102706 DOI: 10.1371/journal.pone.0197649] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 533 |
Abdelhamid L, Luo XM. Retinoic Acid, Leaky Gut, and Autoimmune Diseases. Nutrients 2018;10:E1016. [PMID: 30081517 DOI: 10.3390/nu10081016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 534 |
Takagi T, Naito Y, Mizushima K, Hirai Y, Harusato A, Okayama T, Katada K, Kamada K, Uchiyama K, Handa O, Ishikawa T, Itoh Y. Heme oxygenase-1 prevents murine intestinal inflammation. J Clin Biochem Nutr 2018;63:169-74. [PMID: 30487665 DOI: 10.3164/jcbn.17-133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 535 |
Zai K, Hirota M, Yamada T, Ishihara N, Mori T, Kishimura A, Suzuki K, Hase K, Katayama Y. Therapeutic effect of vitamin D3-containing nanostructured lipid carriers on inflammatory bowel disease. J Control Release 2018;286:94-102. [PMID: 30017723 DOI: 10.1016/j.jconrel.2018.07.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 536 |
Mijan MA, Lim BO. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends. World J Gastroenterol 2018; 24(25): 2673-2685 [PMID: 29991873 DOI: 10.3748/wjg.v24.i25.2673] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 69] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 537 |
Jiao B, Shi A, Wang Q, Binks BP. High-Internal-Phase Pickering Emulsions Stabilized Solely by Peanut-Protein-Isolate Microgel Particles with Multiple Potential Applications. Angew Chem 2018;130:9418-22. [DOI: 10.1002/ange.201801350] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 538 |
Jiao B, Shi A, Wang Q, Binks BP. High-Internal-Phase Pickering Emulsions Stabilized Solely by Peanut-Protein-Isolate Microgel Particles with Multiple Potential Applications. Angew Chem Int Ed Engl 2018;57:9274-8. [PMID: 29845713 DOI: 10.1002/anie.201801350] [Cited by in Crossref: 157] [Cited by in F6Publishing: 164] [Article Influence: 31.4] [Reference Citation Analysis]
|
| 539 |
Cui G, Yuan A. A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease. Front Med (Lausanne). 2018;5:183. [PMID: 29971235 DOI: 10.3389/fmed.2018.00183] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 540 |
Ruiz MA, Kaiser RL, Piron – Ruiz L, Peña-arciniegas T, Castiglioni L, Samara Saran P, De Quadros LG, Gouvea Faria MA, Siqueira RC, Liedtke Kaiser FS, Comenalli Marques JF. Crohn’s disease patients effectively mobilize peripheral blood stem cells to perform autologous haematopoietic stem cell transplantation.. [DOI: 10.1101/348763] [Reference Citation Analysis]
|
| 541 |
Rahmouni O, Vignal C, Titécat M, Foligné B, Pariente B, Dubuquoy L, Desreumaux P, Neut C. High carriage of adherent invasive E. coli in wildlife and healthy individuals. Gut Pathog 2018;10:23. [PMID: 29946365 DOI: 10.1186/s13099-018-0248-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 542 |
Bakke D, Sun J. Ancient Nuclear Receptor VDR With New Functions: Microbiome and Inflammation. Inflamm Bowel Dis 2018;24:1149-54. [PMID: 29718408 DOI: 10.1093/ibd/izy092] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 543 |
Xun Z, Zhang Q, Xu T, Chen N, Chen F. Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles. Front Microbiol. 2018;9:1136. [PMID: 29899737 DOI: 10.3389/fmicb.2018.01136] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 544 |
Roig J, Saiz ML, Galiano A, Trelis M, Cantalapiedra F, Monteagudo C, Giner E, Giner RM, Recio MC, Bernal D, Sánchez-Madrid F, Marcilla A. Extracellular Vesicles From the Helminth Fasciola hepatica Prevent DSS-Induced Acute Ulcerative Colitis in a T-Lymphocyte Independent Mode. Front Microbiol 2018;9:1036. [PMID: 29875750 DOI: 10.3389/fmicb.2018.01036] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 545 |
Wei B, Zhang R, Zhai J, Zhu J, Yang F, Yue D, Liu X, Lu C, Sun X. Suppression of Th17 Cell Response in the Alleviation of Dextran Sulfate Sodium-Induced Colitis by Ganoderma lucidum Polysaccharides. J Immunol Res 2018;2018:2906494. [PMID: 29888292 DOI: 10.1155/2018/2906494] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 546 |
Hvas CL, Bendix M, Dige A, Dahlerup JF, Agnholt J. Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacol Immunotoxicol 2018;40:446-60. [PMID: 29745777 DOI: 10.1080/08923973.2018.1469144] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 547 |
de Meij T, de Groot E, Peeters C, de Boer N, Kneepkens C, Eck A, Benninga M, Savelkoul P, van Bodegraven A, Budding A. Variability of core microbiota in newly diagnosed treatment-naïve paediatric Inflammatory Bowel Disease patients.. [DOI: 10.1101/317263] [Reference Citation Analysis]
|
| 548 |
Tekeli İO, Ateşşahin A, Sakin F, Aslan A, Çeribaşı S, Yipel M. Protective effects of conventional and colon-targeted lycopene and linalool on ulcerative colitis induced by acetic acid in rats. Inflammopharmacol 2019;27:313-22. [DOI: 10.1007/s10787-018-0485-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 549 |
Lee S, Metcalfe A, Raman M, Leung Y, Aghajafari F, Letourneau N, Panaccione R, Kaplan GG, Seow CH. Pregnant Women with Inflammatory Bowel Disease Are at Increased Risk of Vitamin D Insufficiency: A Cross-Sectional Study. J Crohns Colitis 2018;12:702-9. [PMID: 29546360 DOI: 10.1093/ecco-jcc/jjy030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 550 |
Mahadevan U, Silverberg MS. Inflammatory Bowel Disease-Gastroenterology Diamond Jubilee Review. Gastroenterology 2018;154:1555-8. [PMID: 29550591 DOI: 10.1053/j.gastro.2017.12.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 551 |
Ghattamaneni NKR, Panchal SK, Brown L. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease. Pharmacol Res 2018;132:99-107. [PMID: 29680446 DOI: 10.1016/j.phrs.2018.04.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 552 |
Mir FA, Kane SV. Health Maintenance in Inflammatory Bowel Disease. Curr Gastroenterol Rep 2018;20. [DOI: 10.1007/s11894-018-0621-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 553 |
Zhu C, Song K, Shen Z, Quan Y, Tan B, Luo W, Wu S, Tang K, Yang Z, Wang X. Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis. Mol Med Rep 2018;17:7567-74. [PMID: 29620246 DOI: 10.3892/mmr.2018.8833] [Cited by in Crossref: 21] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 554 |
Löf Granström A, Amin L, Arnell H, Wester T. Increased Risk of Inflammatory Bowel Disease in a Population-based Cohort Study of Patients With Hirschsprung Disease. J Pediatr Gastroenterol Nutr 2018;66:398-401. [PMID: 28922260 DOI: 10.1097/MPG.0000000000001732] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 555 |
Giuffrida P, Corazza GR, Di Sabatino A. Old and New Lymphocyte Players in Inflammatory Bowel Disease. Dig Dis Sci 2018;63:277-88. [PMID: 29275447 DOI: 10.1007/s10620-017-4892-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 556 |
Salih A, Widbom L, Hultdin J, Karling P. Smoking is associated with risk for developing inflammatory bowel disease including late onset ulcerative colitis: a prospective study. Scand J Gastroenterol 2018;53:173-8. [PMID: 29262738 DOI: 10.1080/00365521.2017.1418904] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 557 |
Weimers P, Munkholm P. The Natural History of IBD: Lessons Learned. Curr Treat Options Gastroenterol 2018;16:101-11. [PMID: 29359275 DOI: 10.1007/s11938-018-0173-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 558 |
Wu D, Wu K, Zhu Q, Xiao W, Shan Q, Yan Z, Wu J, Deng B, Xue Y, Gong W, Lu G, Ding Y. Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway. Mediators Inflamm. 2018;2018:3048532. [PMID: 29507526 DOI: 10.1155/2018/3048532] [Cited by in Crossref: 19] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 559 |
Mizoguchi A, Yano A, Himuro H, Ezaki Y, Sadanaga T, Mizoguchi E. Clinical importance of IL-22 cascade in IBD. J Gastroenterol 2018;53:465-74. [PMID: 29075900 DOI: 10.1007/s00535-017-1401-7] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 22.6] [Reference Citation Analysis]
|
| 560 |
Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol 2018;15:39-49. [PMID: 29018271 DOI: 10.1038/nrgastro.2017.136] [Cited by in Crossref: 374] [Cited by in F6Publishing: 328] [Article Influence: 74.8] [Reference Citation Analysis]
|
| 561 |
Breit S, Kupferberg A, Rogler G, Hasler G. Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders. Front Psychiatry 2018;9:44. [PMID: 29593576 DOI: 10.3389/fpsyt.2018.00044] [Cited by in Crossref: 388] [Cited by in F6Publishing: 335] [Article Influence: 77.6] [Reference Citation Analysis]
|
| 562 |
Dulai PS, Singh S, Ohno-Machado L, Sandborn WJ. Population Health Management for Inflammatory Bowel Disease. Gastroenterology 2018;154:37-45. [PMID: 29122544 DOI: 10.1053/j.gastro.2017.09.052] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 563 |
Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11:1-10. [PMID: 29285689 DOI: 10.1007/s12328-017-0813-5] [Cited by in Crossref: 533] [Cited by in F6Publishing: 458] [Article Influence: 88.8] [Reference Citation Analysis]
|
| 564 |
Im JP, Ye BD, Kim YS, Kim JS. Changing treatment paradigms for the management of inflammatory bowel disease. Korean J Intern Med 2018;33:28-35. [PMID: 29334728 DOI: 10.3904/kjim.2017.400] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 565 |
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017;390:2769-78. [PMID: 29050646 DOI: 10.1016/S0140-6736(17)32448-0] [Cited by in Crossref: 2628] [Cited by in F6Publishing: 2430] [Article Influence: 438.0] [Reference Citation Analysis]
|
| 566 |
Kamm MA. Rapid changes in epidemiology of inflammatory bowel disease. Lancet 2017;390:2741-2. [PMID: 29050647 DOI: 10.1016/S0140-6736(17)32669-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 567 |
Zhang X, Wei L, Wang J, Qin Z, Lu Y, Zheng X, Peng Q, Ye Q, Ai F, Liu P, Wang S, Li G, Shen S, Ma J. Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice. Front Immunol. 2017;8:1774. [PMID: 29326691 DOI: 10.3389/fimmu.2017.01774] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 568 |
Browne AS, Kelly CR. Fecal Transplant in Inflammatory Bowel Disease. Gastroenterol Clin North Am 2017;46:825-37. [PMID: 29173524 DOI: 10.1016/j.gtc.2017.08.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 569 |
Ma C, Moran GW, Benchimol EI, Targownik LE, Heitman SJ, Hubbard JN, Seow CH, Novak KL, Ghosh S, Panaccione R, Kaplan GG. Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study. Am J Gastroenterol 2017;112:1840-8. [PMID: 29087396 DOI: 10.1038/ajg.2017.394] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 18.2] [Reference Citation Analysis]
|
| 570 |
Tocia C, Achim AC, Alexandrescu L, Dumitru E. Inflammatory Bowel Diseases: focus on epidemiology. ARS Medica Tomitana 2017;23:204-211. [DOI: 10.1515/arsm-2017-0038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 571 |
Li Y, Qian J. What Are the Unanswered Questions and Unmet Needs in Inflammatory Bowel Disease Management in Asia? Chinese Medical Journal 2017;130:2647-2649. [DOI: 10.4103/0366-6999.218018] [Reference Citation Analysis]
|
| 572 |
Su J, Li C, Yu X, Yang G, Deng J, Su Z, Zeng H, Chen J, Zhang X, Lai X. Protective Effect of Pogostone on 2,4,6-Trinitrobenzenesulfonic Acid-Induced Experimental Colitis via Inhibition of T Helper Cell. Front Pharmacol 2017;8:829. [PMID: 29204117 DOI: 10.3389/fphar.2017.00829] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 573 |
Santos MPC, Gomes C, Torres J. Familial and ethnic risk in inflammatory bowel disease. Ann Gastroenterol. 2018;31:14-23. [PMID: 29333063 DOI: 10.20524/aog.2017.0208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 574 |
Suman S, Hussin F, Malik A, Ho S, Hilmi I, Leow A, Goh K. Feature Selection and Classification of Ulcerated Lesions Using Statistical Analysis for WCE Images. Applied Sciences 2017;7:1097. [DOI: 10.3390/app7101097] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 575 |
Lee C, Kim BG, Kim JH, Chun J, Im JP, Kim JS. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. International Immunopharmacology 2017;51:47-56. [DOI: 10.1016/j.intimp.2017.07.023] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 17.7] [Reference Citation Analysis]
|
| 576 |
Josephine Ni, Gary D. Wu, Lindsey Albenberg, Vesselin T. Tomov. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 2017;14. [PMID: 28743984 DOI: 10.1038/nrgastro.2017.88] [Cited by in Crossref: 795] [Cited by in F6Publishing: 728] [Article Influence: 132.5] [Reference Citation Analysis]
|
| 577 |
Squires SI, Boal AJ, Lamont S, Naismith GD. Implementing a self-management strategy in inflammatory bowel disease (IBD): patient perceptions, clinical outcomes and the impact on service. Frontline Gastroenterol 2017;8:272-8. [PMID: 29067153 DOI: 10.1136/flgastro-2017-100807] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 578 |
Elhenawy W, Oberc A, Coombes BK. A polymicrobial view of disease potential in Crohn's-associated adherent-invasive E. coli. Gut Microbes 2018;9:166-74. [PMID: 28914579 DOI: 10.1080/19490976.2017.1378291] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 579 |
Allen JM, Mailing LJ, Cohrs J, Salmonson C, Fryer JD, Nehra V, Hale VL, Kashyap P, White BA, Woods JA. Exercise training-induced modification of the gut microbiota persists after microbiota colonization and attenuates the response to chemically-induced colitis in gnotobiotic mice. Gut Microbes 2018;9:115-30. [PMID: 28862530 DOI: 10.1080/19490976.2017.1372077] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 580 |
Aniwan S, Park SH, Loftus EV Jr. Epidemiology, Natural History, and Risk Stratification of Crohn's Disease. Gastroenterol Clin North Am 2017;46:463-80. [PMID: 28838409 DOI: 10.1016/j.gtc.2017.05.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 581 |
Lahey KA, Ronaghan NJ, Shang J, Dion SP, Désilets A, Leduc R, MacNaughton WK. Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function. PLoS One 2017;12:e0180259. [PMID: 28671992 DOI: 10.1371/journal.pone.0180259] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 582 |
Kaplan GG. Editorial: the Millennium study cohort-evaluating environmental determinates of IBD in the 21st century. Aliment Pharmacol Ther 2017;46:63-4. [PMID: 28589585 DOI: 10.1111/apt.14077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 583 |
Kaplan GG. Pumping Iron: Exploring Novel Gene-environment Interactions in the Inflammatory Bowel Diseases. Inflamm Bowel Dis 2017;23:1096-7. [PMID: 28604416 DOI: 10.1097/MIB.0000000000001164] [Reference Citation Analysis]
|
| 584 |
Mahadevan U. How to Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities. Gastroenterology 2017;152:1813-6. [PMID: 28461195 DOI: 10.1053/j.gastro.2017.04.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 585 |
Hammer T, Lophaven SN, Nielsen KR, von Euler-Chelpin M, Weihe P, Munkholm P, Burisch J, Lynge E. Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development. Aliment Pharmacol Ther 2017;45:1107-14. [PMID: 28176348 DOI: 10.1111/apt.13975] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 586 |
Kellermayer R. Challenges for epigenetic research in inflammatory bowel diseases. Epigenomics 2017;9:527-38. [PMID: 28343422 DOI: 10.2217/epi-2016-0155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 587 |
Colombel JF, Mahadevan U. Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms. Gastroenterology 2017;152:309-12. [PMID: 27960091 DOI: 10.1053/j.gastro.2016.12.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 9.2] [Reference Citation Analysis]
|
